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Objective 
Respiratory Syncytial Virus or RSV is the most common cause of lower 
respiratory tract infections in infants and young children. Often, the more severe 
the episode of RSV, the more likely wheezing will be present with the illness. 
Infants who experience wheezing with a viral infection may develop asthma in the 
future. The purpose of this study, therefore, is to determine if there is a difference 
in the incidence of RSV positive wheezing illnesses during infancy among infants 
who differ in length of exclusive breast or formula feeding. Extraneous variables 
such as gender of the infant, maternal history of allergy and asthma, smoking in 
the infant’s environment, and ethnicity of the infant are also thought to play a role 
in the development of respiratory illnesses. These variables will be examined in 
addition to breastfeeding to determine if they have an effect on the incidence of 
RSV positive wheezing illnesses, and counteract, conceal, or augment any 
protective effects of breastfeeding. 
Subjects 
The subjects for this project included the 287 infants participating in the 
Childhood Origins of Asthma (COAST) project, a prospective, longitudinal study 
at the University of Wisconsin Asthma and Allergy Clinical Research Unit in 
Madison, Wisconsin being conducted to elucidate possible causes for asthma.  
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Procedures 
The Statistical Package for Social Sciences (SPSS) version 10.0 was 
utilized for data analysis. The Chi-Square procedure was employed to determine 
if length of exclusive breastfeeding is independent of gender, ethnicity, smoke 
exposure, and maternal history of allergy and/or asthma. Binary logistic 
regression analysis was applied to determine if a relationship exists among RSV 
and RSV positive wheezing illnesses and length of exclusive breastfeeding, 
gender of the infant, ethnicity of the infant, smoke exposure, and maternal history 
of allergy and/or asthma. Finally, multivariate logistic regression analysis was 
carried out to determine if the incidence of RSV and RSV positive wheezing 
illnesses were affected when examining all of the variables in combination with 
each other.  
Results 
Neither formula feeding nor length of exclusive breastfeeding was 
associated with gender, ethnicity, or maternal history of allergy and/or asthma. 
Infants exposed to smoke were significantly less likely, however, to have been 
breastfed or were breastfed for shorter time periods (p = 0.043). With exclusive 
breastfeeding greater than or equal to six months serving as the reference 
category, no significant relationship was found between presence of RSV and 
never breastfeeding or exclusive breastfeeding less than six months. No 
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significant connection was revealed between RSV positive wheezing illnesses and 
never breastfeeding or exclusive breastfeeding less than six months. Infants with a 
maternal history of both allergy and asthma were significantly more likely to have 
RSV positive wheezing illnesses when examined alone (p = 0.036) and while 
controlling for feeding history, gender, ethnicity, and smoke exposure (p = 0.032). 
Conclusions 
As established by the results, this study demonstrates that breastfeeding, 
even for prolonged periods of time, does not seem to protect against wheezing 
illnesses in children with a maternal history of allergy and/or asthma. However, 
there is no reason to discourage families from this method of feeding. The general 
benefits of breastfeeding for both infants and mothers are simply too great to 
ignore. 
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CHAPTER 1 
Definition of Terms 
 Apgar score-a measure of an infant’s color, heart beat, respiration, 
response to stimuli, and muscle tone five minutes after birth in order to determine 
his or her health status. A score of seven to ten is considered normal.  
Atopy-refers to a variety of disorders such as asthma, eczema, allergic 
rhinitis, and food allergy that is associated with an elevated level of IgE 
antibodies. The amount of IgE antibody that individuals make can be assessed 
through skin or radioallergosorbent (RAST) testing (tests to measure allergy). 
Bronchiolitis-inflammation of the bronchioles, the smallest branches of 
the air passages in the lungs through which air flows.   
Colostrum-the thin, watery fluid produced in the mother during the first 
few days of an infant’s life to provide nourishment prior to the production of 
mature breast milk. It is rich in proteins, especially antibodies, and is low in 
carbohydrates and fats.   
Cytokines-cellular messengers, some of which may play a role in asthma 
development. 
Immunoglobulin A-a plasma protein (antibody) that is also found in both 
the respiratory and gastrointestinal tracts; it plays a role in immunity by acting 
against bacterial cells and viruses as a first line of defense. 
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Immunoglobulin E-a plasma protein (antibody) that serves as a marker of 
allergic response (the so-called “allergic antibody”). 
Infancy-the period from birth until 12 months of age. 
Lactoferrin-protein found in breast milk that prevents bacterial growth by 
binding available iron. 
Oligosaccharides-carbohydrates that bind harmful microorganisms in the 
body. 
Respiratory syncytial virus or RSV-virus that attacks the mucous 
membranes of the upper and lower respiratory tract causing symptoms ranging 
from mild cold symptoms to severe respiratory distress that may result in death. 
The virus is the most frequent cause of wheezing illnesses in the first two years of 
life. 
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Introduction 
Asthma is a chronic lung disease characterized by shortness of breath, 
wheezing, and inflammation leading to airway obstruction (Morgan & Martinez, 
1992). As noted by Anderson, Butland, and Strachan (1994), asthma prevalence 
has increased in industrialized nations over the past several decades. According to 
the American Lung Association (2001), approximately 4.8 million children are 
affected by asthma with the highest number of new cases diagnosed in children 
less than five years of age. Furthermore, the American Lung Association (2001) 
estimates that the cost of asthma totals approximately 3.2 billion dollars, and that 
10.1 million school days are missed each year due to this disease; thus, indirectly 
raising the cost of asthma even further. Although there are numerous 
environmental risk factors for asthma, the disease itself may be manifested in 
infancy. 
Respiratory Syncytial Virus or RSV is the most common cause of lower 
respiratory tract infections in infants and young children (Glezen, Taber, Frank, & 
Kasel, 1986). According to the American Lung Association (2001), RSV results 
in 90,000 hospitalizations and 4,500 deaths a year in this population. 
Additionally, roughly 60% of children will have an RSV positive lower 
respiratory tract infection during infancy, most likely of a more severe nature than 
at other times in the life span (Glezen et al., 1986; Openshaw, 1995). RSV can be 
associated with coughing, wheezing, bluish skin, shortness of breath, nasal 
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flaring, and rapid breathing. The symptoms appear similar in nature to childhood 
and adult asthma (Landau, 1994). Often, the more severe the episode of RSV, the 
more likely wheezing will be present with the illness (Morgan & Martinez, 1992). 
Therefore, children who experience wheezing with a viral infection before the age 
of three years are thought to be more likely to develop asthma in the future 
(Martinez et al., 1995).  
The timing of this illness is important for many reasons. First of all, as 
found from a study using animal models, a respiratory viral infection in the early 
stages of life may produce long lasting, adverse effects in the respiratory tract 
(Strachan, 1992). For example, one side effect is an increased number of 
bronchiolar mast cells (Castleman, Sorkness, Lemanske, & McAllister, 1990). In 
turn, these bronchiolar mast cells produce histamine, a substance that plays a role 
in the inflammatory process. These early viral respiratory infections also result in 
airway hyperresponsiveness or spasms in the respiratory tract (Castleman et al., 
1990). Since infancy is an important time for lung development, these damaging 
results are not surprising. Moreover, infancy is also a time for bolstering the 
otherwise immature immune system. Therefore, if an infant contracts a respiratory 
virus while both the respiratory and immune systems are still in the process of 
developing, permanent damage, such as narrowed, swollen, spasmodic airways 
causing labored breathing and thick mucous formation in the lungs, may result. 
What if there was a way, however, to reduce the number of wheezing episodes 
RSV Positive Wheezing Illnesses 13
associated with or severity of RSV during infancy? Would this lead to a decreased 
risk of childhood asthma for susceptible individuals? 
Over the years, much research has been done regarding the causes of 
respiratory tract infections during infancy. One area in particular that has received 
a great deal of attention is the role of breastfeeding in relation to respiratory 
illnesses. Strong evidence exists that breastfeeding reduces incidence of 
respiratory illnesses during infancy in developing countries or communities 
(Brown, Black, Lopez de Romana, & Creed de Kanashiro, 1989; Cesar, Victora, 
Barros, Santos, & Flores, 1999; Forman, Graubard, Hoffman, Beren, Harley, & 
Bennett, 1984; Lopez-Alarcon, Villalpando, & Fajardo 1997; Victora, Smith, 
Barros, Vaughn, & Fuchs, 1989). As a case in point, Cesar et al. (1999) observed 
that infants from an urban area of Brazil who did not receive breast milk had a 17 
times greater risk of being admitted to the hospital for pneumonia than infants 
who were exclusively breastfed. The effects were especially prominent during the 
first three months of life. In a study carried out in a slum neighborhood near 
Mexico City, Lopez-Alarcon et al. (1997) discovered that infants who were 
exclusively breastfed had less acute respiratory infections and acute respiratory 
infections of shorter duration until four months of age. As a final point, 
Cunningham, Jelliffe, and Jelliffe (1991) reported that infants from urban areas of 
developing nations experience a fourfold increase in deaths from lower 
respiratory tract infections when they were not breastfed.  
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The protective effects of breastfeeding in relation to respiratory illnesses 
in infants from industrialized societies are less clear. Frank et al. (1982) 
conducted a study in the U.S. and found that breastfeeding did not reduce the 
occurrence of upper and lower viral respiratory tract infections in the first year of 
life. Many other studies in developed areas have initially found an association 
between breastfeeding and reduced incidence of respiratory tract illnesses. After 
controlling for other factors in the statistical analysis such as maternal smoking, 
socioeconomic status, and infant birth weight, however, these other factors have 
been found to play more of a role in respiratory illnesses than breastfeeding 
(Fergusson, Horwood, Shannon, & Taylor, 1981; Pullan et al., 1980; Taylor, 
Golding, Wadsworth, & Butler, 1982). Furthermore, in an analysis conducted by 
Bauchner, Leventhal, and Shapiro (1986) to examine the quality of breastfeeding 
research based on certain standards, it was found that most early studies 
supporting breastfeeding did not meet the standards for validity and 
generalizability. Kovar, Serdula, Marks, and Fraser (1984) also came up with 
conflicting information about the protective properties of breastfeeding in relation 
to respiratory illnesses in an early literature review. They found that many of the 
studies conducted up until that point were poorly designed and failed to account 
for the impact of confounding variables, length of breastfeeding, and exclusivity 
of breastfeeding.  
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More recently, however, many of the studies conducted in developed 
countries on breastfeeding and infectious disease have followed some of the more 
stringent standards set forth by Bauchner et al. (1986) and Kramer (1988) that 
include the following: 1). Defining outcomes (i.e. respiratory tract infections) 
more clearly, 2). Controlling for extraneous variables such as sex of the child, 
smoking, ethnicity, socioeconomic status, and parental history of allergy and 
asthma, 3). Ensuring the length of time during which breastfeeding is studied is of 
adequate duration, 4). Examining breastfeeding in terms of exclusivity, and 5). 
Avoiding detection bias by conducting prospective analysis of illness. After 
implementing the standards into the research protocol, several studies have then 
found an inverse relationship between duration of breastfeeding and the incidence 
of respiratory illnesses, particularly in the early months of life (Baker, Taylor, & 
Henderson,1998; Beaudry, Dufor, & Marcoux, 1995; Cunningham, 1979; 
Cushing et al. 1998; Howie, Forsyth, Ogston, Clark, & du V Florey, 1990; 
Nafstad, Jaakkola, Hagen, Botten, & Konegerud, 1996; Pisacane, et al., 1994; 
Raisler, Alexander, & O’Campo, 1999; Wright et al., 1989; Wright, Bauer, 
Naylor, Sutcliffe, & Clark, 1998). Other studies have even found the benefits to 
extend into childhood (Burr et al., 1993; Dell & To, 2001; Oddy et al., 1999; 
Rylander, Pershagen, Eriksson, & Nordvall, 1993; Saarinen, & Kajosaari, 1995; 
Wright, Holberg, Taussig, &Martinez, 1995; Wilson et al., 1998; Wright, 
Holberg, Taussig, & Martinez, 2001b). 
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Breastfeeding could potentially reduce the incidence or severity of 
respiratory illnesses for many reasons. First of all, colostrum (or “first” milk) is 
thought to contain properties that reduce the severity of RSV (Downham, Scott, 
Sims, Webb, & Gardner, 1976). Secondly, breast milk is believed to contain an 
array of factors to enhance immunity (Pabst, 1997). Finally, breast milk may even 
aid in the development of the immature lungs (Martinez, Morgan, Wright, & 
Taussig, 1988).  
In conclusion, numerous discrepancies exist among studies examining 
infant feeding practices and respiratory illnesses. A great deal of current research 
points to a positive association between breastfeeding and reduced incidence and 
severity of respiratory illnesses, particularly in the early months of life. Research 
also shows that breast milk may contain antibodies as well as other compounds 
that enhance immune function. However, many other studies have found that 
breastfeeding is simply not as protective against respiratory illnesses in well-
developed areas due to variables such as environmental and social factors. 
Therefore, the controversy remains. 
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Statement of the Problem 
Currently, a prospective, longitudinal study is underway at the University 
of Wisconsin Asthma and Allergy Clinical Research Unit located in Madison, 
Wisconsin. The Childhood Origins of Asthma [COAST] study is following a 
group of 287 infants from the Madison area community with a family history of 
allergy and/or asthma to elucidate possible causes for the disease. The principal 
investigators of this study postulate that asthma will develop if a child has the 
genetic predisposition for the disease and is exposed to a particular environmental 
factor at a certain point in time during infancy. The environmental factor in 
question is RSV. Therefore, if the COAST hypothesis is accepted, an infant who 
has the genetic potential for asthma and experiences an RSV positive wheezing 
illness at a crucial point in time during infancy may develop recurrent wheezing 
or asthma later in life.   
The purpose of this subsidiary study, therefore, is to determine if there is a 
difference in the incidence of RSV positive wheezing illnesses during the first 
year of life among the infants participating in the COAST study who differ in 
length of exclusive breast or formula feeding. Extraneous variables such as gender 
of the infant, maternal history of allergy and asthma, smoking in the infant’s 
environment, and ethnicity of the infant are also thought to play a role in the 
development of respiratory illnesses. These variables will be examined in addition 
to breastfeeding to determine if they have an effect on the incidence of RSV 
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positive wheezing illnesses, and negate, mask, or amplify any protective effects of 
breastfeeding. 
The research hypothesis for this study is that a significant relationship 
exists in the incidence of RSV positive wheezing illnesses among a group of 287 
infants from the Madison, Wisconsin area community who differ in terms of 
feeding mode. It remains unclear whether or not the relationship will remain 
significant after controlling for sex of the infant, ethnicity of the infant, smoking 
in the infant’s environment, and maternal history of allergy and asthma. 
The null hypothesis for this study is that there is no statistically significant 
relationship in the incidence of RSV positive wheezing illnesses during infancy 
for a group of infants who differ in mode of feeding, even while controlling for 
extraneous variables such as gender, maternal history of allergy and/or asthma, 
smoke exposure, and ethnicity. 
If exclusive breastfeeding is found to reduce the incidence of RSV 
positive wheezing illnesses, it will provide evidence that this method of feeding 
may be associated with decreased severity of these infections, since wheezing is 
associated with lower respiratory tract infections of greater seriousness. 
Therefore, the infant’s respiratory system will have time to develop properly so 
that adverse, long-term complications such as asthma can be reduced. Acceptance 
of the hypothesis will also offer further support to encourage exclusive 
breastfeeding for at least the first six months of life in addition to supplemental 
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breastfeeding alongside cereals, fruits, vegetables, and meats until one year of age 
as advised by the American Academy of Pediatrics (1997) and the American 
Dietetic Association (Dobson & Murtaugh, 2001). It will also help meet the goals 
set forth by the US Department of Health and Human Services in Healthy People 
2010 that include increasing the rate of initial breastfeeding to 75%, increasing 
the rate of breastfeeding at 6 months to 50%, and increasing the rate of 
breastfeeding at 12 months to 25% (http://www.health.gov/healthypeople). 
Currently, only 64% of US women breastfeed at birth, only 29% continue to 
breastfeed until six months post partum, and only 16% continue to breastfeed at 
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CHAPTER 2 
Review of Literature 
 Breastfeeding and its relation to occurrence of disease in both infancy and 
childhood is a controversial topic. Several studies have found a positive 
association between breastfeeding and a reduced occurrence of many acute and 
chronic illnesses, while other studies have appeared in the literature and refuted 
those findings. In this review, the functional properties of breast milk that may 
assist in promoting health are outlined. Additionally, a description of the studies 
that have found varying conclusions when examining the role of breastfeeding in 
regard to disease prevention during different stages of the life cycle is included, 
along with speculations as to why some studies are more convincing than others. 
A discussion on the importance of examining breastfeeding from the angle of 
exclusivity is also provided. Finally, a debate over the impact that potential 
confounding variables may have in the relationship between breastfeeding and 
respiratory illnesses is included. These extraneous variables include sex of the 
infant, ethnicity of the infant, smoking in the infant’s environment, and maternal 
history of allergy and/or asthma. 
The Benefits of Breast Milk 
 It is a well known fact that breastfeeding affords numerous benefits to 
both the mother and child. Some of the more commonly known benefits of 
breastfeeding include strengthening of the mother/child bond, providing the infant 
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with the perfect composition of nutrients to meet his or her changing needs during 
growth and development, assisting in development of cognitive function, aiding in 
digestion, and decreasing costs associated with infant feeding. Additionally, 
breastfeeding reduces an infant’s contact with harmful pathogens in the 
environment (Heinig, 2001). For instance, an infant who is breastfeeding may 
spend more time with his or her mother and less time in the presence of strangers 
where exposure to illnesses is increased. Also, an infant who is breastfeeding is 
less likely to come into contact with contaminated water or food, a situation that 
is of concern particularly in developing countries as it can lead to severe diarrhea, 
emesis, dehydration, and death.  
Other than these well-known benefits of breastfeeding, there are many 
compounds found in breast milk that play important and somewhat complex roles 
in human development, disease prevention, and illness reduction. Although infant 
formulas that are cow’s milk or soy based are designed to mimic the composition 
of breast milk as closely as possible, they do not contain factors that strengthen 
the infant’s immune system. For instance, “first milk” or colostrum, as 
documented by Pabst (1997), contains beneficial components, such as neutrophils 
and mononuclear cells. The mononuclear cells assist in the development of the 
immune system by inducing IgA production, and the neutrophils help reduce 
inflammation. Moreover, Lawrence (2001) and Hanson (1998) both noted that the 
secretory IgA, that increases in breast milk as maternal exposure to certain 
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pathogens in the environment increases, acts against respiratory viruses and 
bacteria that the infant has come into contact with to prevent them from attaching 
to mucous membranes. Downham et al. (1976) also believed that the secretory 
IgA found in the colostrum may act specifically against RSV and reduce the 
severity of the illness. Finally, Sarfati, Vanderbeeken, Rubio-Trujillo, Duncan, 
and Delespesse (1986) pointed out that colostrum contains components that 
control IgE, an antibody that promotes allergic reaction and inflammation.  
As emphasized by Peat, Allen, and Oddy (1999) and Pabst (1997), breast 
milk also contains oligosaccharides that inhibit pathogens from affixing to the 
walls of the respiratory tract, lipids that impart an antibacterial action, and growth 
factors that enable the immature immune system to develop. Martinez et al. 
(1988) postulated that breast milk plays a role in enabling lung tissue to mature as 
well. Breast milk may also contain particles that regulate the immune response by 
decreasing inflammation and the risk of an allergic reaction, two factors of great 
importance in the development of asthma (Heinig, 2001). Such a protective factor 
found in human milk is lactoferrin. This compound may provide antibacterial, 
antiviral, and anti-inflammatory protection through control of cytokine production 
(Hamosh, 2001). Prolactin and nucleotides that enhance immune function have 
also been discovered in human milk (Hamosh, 2001). In fact, prolactin’s role in 
tissue development may be the reason why the thymus, an organ that plays a role 
in immunity, is found to be larger in breastfed infants (Pabst, 1997).  
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The exact ways in which all or some of these factors may contribute to a 
reduced incidence of respiratory illnesses in each individual is not entirely clear. 
However, the knowledge surrounding the composition of breast milk helps 
provide support to the belief that breast milk, unlike formula, has the potential to 
confer numerous beneficial properties to infants to enhance their health status and 
prevent or reduce acute and chronic illnesses (Oddy, W. H., 2001). 
Breastfeeding and respiratory illnesses during infancy 
 When taking into account the current knowledge surrounding the makeup 
of breast milk, it is easy to realize why so many studies have been conducted on 
breastfeeding and illnesses. It seems logical to assume that it would offer 
protection against a host of diseases. However, the answers about the potential 
benefits are not always lucid making it difficult to make the aforementioned 
assumption. This is due to the fact that respiratory infections such as RSV positive 
wheezing illnesses are associated with numerous risk factors that may be both 
independent of and related to breastfeeding. Holberg et al. (1991) proposed risk 
factors such as sex of the infant, overcrowding, ethnicity, smoke exposure, 
socioeconomic status, birth weight, and birth month. In fact, when Holberg et al. 
(1991) looked at the relationship among the duration and exclusivity of formula 
feeding and breastfeeding for less than one month, one to three months, four to six 
months, and greater than six months, and RSV associated lower respiratory tract 
infections during the first year of life, they discovered that although breastfeeding 
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was protective in and of itself, the protective effects of this feeding method on 
reducing incidence of illness were more profound among infants of lower 
socioeconomic status. On a similar note, Rubin et al. (1990) studied a group of 
infants living in Coppenhagen, Denmark who came from small, middle class 
families and were born to older mothers. They found the number of 
gastrointestinal, upper respiratory, and lower respiratory illnesses occurring each 
month to be similar in infants receiving either 100% breast milk or a greater 
amount of breast milk than formula compared to those infants receiving equal 
amounts of formula and breast milk, more formula than breast milk, or formula 
only. Once again, any defensive assets of breast milk may have been diluted in the 
midst of a middle to upper class environment. 
Porro, Indinnimeo, Antognoni, Midulla, and Criscione (1993) examined 
both the severity of wheezing illnesses and the onset of wheezing illnesses. They 
reported that exclusive breastfeeding delayed the onset and reduced the severity 
of wheezing, but that other factors such as family history of atopy and smoking in 
the household played a larger role in the development of wheezing. Both 
Fergusson et al. (1981) and Taylor at al. (1982) initially observed a significant 
decrease in respiratory illnesses among breastfed infants but observed that the 
significance disappeared after controlling for certain environmental, social, and 
economic factors. Finally, in a case-control study conducted by Leventhal, 
Shapiro, Aten, Berg, and Egerter (1986) it was found that, in general, 
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breastfeeding reduced infectious illnesses such as bronchiolitis, pneumonia, 
gastroenteritis, and meningitis. However, after stratifying the illnesses based on 
severity, it was discovered that breastfeeding did not alter the severity of the 
illness. Thus, Leventhal et al. (1986) speculated that hospitalizations are reduced 
in breastfed infants most likely because of a “physician’s unwillingness to 
separate a nursing mother and her infant and the belief that a nursing mother is 
more competent than a non-nursing mother and, therefore, more capable of taking 
care of the sick child at home” (p. 899). These results point to the notion that the 
benefits of breastfeeding can be masked when other factors are taken into 
consideration.  
A growing number of studies, nonetheless, have controlled for these 
extraneous variables in the statistical analysis and have still found protective 
effects of breastfeeding against respiratory illnesses. Cushing et al. (1998) 
examined incidence of lower respiratory tract illnesses among a group of infants 
from a middle class, well-educated population born into non-smoking households 
in Albequerque, New Mexico. After controlling for birth order, sex, ethnicity, 
parental history of asthma or atopy, income, and maternal education through 
multivariate analysis, they found an inverse relationship between the number of 
lower respiratory tract illnesses and length of exclusive breastfeeding in addition 
to an inverse relationship between the duration of upper and lower respiratory 
tract illnesses combined and length of exclusive breastfeeding during the first six 
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months of life. In summary, they claimed this shorter period of both illnesses as 
well as the reduced occurrence of lower respiratory tract illnesses suggests that 
exclusive breastfeeding leads to reduced respiratory illness severity. In an 
additional study by Howie et al. (1990), a protective effect of exclusive 
breastfeeding compared to bottle feeding against cough and wheezing between 
zero to three months and 9 to 12 months was observed among a group of infants 
in an urban area of Scotland. They concluded that breastfeeding might play an 
overall role in reducing the severity of the illnesses. Finally, Pisacane et al. (1994) 
carried out a case-control study in Italy and revealed that breastfeeding lowers the 
risk of hospital admission for pneumonia and bronchiolitis during the first six 
months of life. In conclusion, the researchers determined that detection and 
selection bias were not the reasons for decreased hospital admissions as Leventhal 
et al. (1986) argued because breast-fed and bottle-fed infants were afforded equal 
chances to be classified as cases. 
On top of decreasing the severity, breastfeeding has also been noted to 
reduce the incidence of respiratory illnesses. In a study conducted by Nafstad et 
al. (1996) among a highly educated upper income group in Norway, the 
researchers found that breastfeeding for more than six months imposed a 
protective effect against physician diagnosed lower respiratory tract illnesses, 
specifically pneumonia, bronchitis, and bronchiolitis, in the first year of life, 
despite the presence of maternal smoking. Beaudry et al. (1995) also studied the 
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effect of breastfeeding on respiratory illnesses [defined as influenza, colds, ear 
infections, pneumonia, bronchitis, throat infections, tonsillitis, pharyngitis, 
whooping cough, croup, and wheezing illnesses] among a group of infants from 
Canada and discovered that any amount of breastfeeding resulted in both a lower 
incidence and a reduced number of hospitalizations for respiratory illnesses in the 
first six months of life. In fact, the bottle-fed group experienced approximately 
80% more respiratory infections than the breastfed group when examining feeding 
status without controlling for extraneous variables. Nevertheless, this protective 
effect persisted even when age of the infant, maternal age, smoking, and 
socioeconomic status were included in the statistical analysis.  
In a study conducted in England by Baker et al. (1998), it was found that 
breastfeeding for three months or longer decreased both the prevalence and 
severity of wheezing during the first six months of life even after controlling for 
household crowding and maternal smoking. Among a group of infants 
participating in the Tucson Children’s Respiratory Study in Arizona, Wright et al. 
(1989) examined breastfeeding status and number of lower respiratory tract 
illnesses in the first year of life and discovered that breastfed infants, regardless of 
the length of breastfeeding, had a reduced number of wheezing illnesses in the 
first four months of life. They concluded, however, that the protection did not last 
past the breastfeeding period. Wright et al. (1998) also examined incidence of 
certain respiratory illnesses and length of breastfeeding among infants born into a 
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Navajo Community. The study was designed in such a manner as to limit recall 
problems by collecting data recorded prospectively in the medical record, to limit 
surveillance bias by analyzing the incidence of illnesses rather than 
hospitalizations, and to limit detection bias. The researches found an inverse 
relationship between the length of breastfeeding and frequency of many illnesses, 
including bronchiolitis, pneumonia, and croup.  
Finally, in an early study carried out by Cunningham (1979), it was 
determined that any amount of breastfeeding resulted in a decreased risk of 
certain diseases, including lower respiratory illnesses, as well as hospital 
admissions while controlling for parental education, maternal age, number of 
siblings, low birth weight, and sex. Cunningham et al. (1991) then compiled a 
review of the major studies dealing with breastfeeding and infant health during 
the 1980s and surmised that breastfeeding offers protection against lower 
respiratory tract infections such as wheezing, bronchiolitis, and pneumonia among 
infants from developed countries. Cunningham et al. (1991) also found that the 
benefits of breastfeeding appear to be most significant during the first six months 
of life. Wright, Bauer, Naylor, Sutcliffe, and Clark (1998) stated as well that “the 
evidence of a protective effect of breastfeeding is strongest for this period [the 
first year of life]” (p. 839). 
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Breastfeeding and respiratory illnesses during childhood 
Although the majority of the evidence shows the strongest effects of 
breastfeeding to exist during the early months of life, other studies have shown 
the effects to extend into childhood. Subsequent to Dell and To’s (2001) 
examination of data collected on children from Canada through the first two years 
of life, the researchers found that breastfeeding, without regard to exclusivity, for 
greater than nine months resulted in a decreased risk of asthma during these early 
years of life. Rylander et al. (1993) studied factors related to the development of 
wheezing bronchitis and asthma up until the age of four years and found, among 
other things, that breastfeeding for less than three months increased the risk of 
these respiratory illnesses.  
Additional researchers have studied children further along in the life cycle 
and have reported that breastfeeding during infancy confers protection against a 
number of respiratory illnesses. Oddy et al. (1999) examined the relationship 
between length of exclusive breastfeeding and development of asthma in six year-
old children in Western Australia while controlling for sex of the child, 
gestational age, smoking in the household, and day care. They discovered that 
exclusive breastfeeding for at least the first four months of life resulted in both a 
lower risk of asthma and atopy by age six as well as a delay in the onset of 
wheezing and asthma. Wilson et al. (1998) studied a group of children from 
Dundee, Scotland until seven years of age and concluded that children who were 
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exclusively breastfed for at least three and one-half months experience a 
decreased number of respiratory illnesses in childhood. Respiratory illnesses were 
defined as persistent coughing, wheezing, and breathlessness. After following a 
group of infants in Helsinki, Finland until 17 years of age, Saarinen and Kajosaari 
(1995) determined that exclusive breastfeeding, especially for six months or 
longer and despite a family history of atopy, afforded a significant protective 
effect against atopic diseases, including respiratory allergies such as allergic 
asthma. It is important to note, though, that although respiratory allergy includes 
wheezing associated with respiratory infections, the authors did not include 
wheezing in their definition of respiratory allergy when examining these young 
adults.  
Regardless of the abovementioned evidence, the relationship between 
breastfeeding and the protective effects lasting into childhood remains 
controversial. While observing a group of children in South Wales with a family 
history of allergic disease until seven years of age, Burr et al. (1993) established 
that length of breastfeeding was protective against wheezing in atopic children 
until two years of age. Thereafter, it was only protective in non-atopic children; 
however, only a small percentage of the study population exclusively breastfed. In 
a case-control study including approximately 23,800 students enrolled in the 
public school system in a suburban residential area near Tokyo, Japan carried out 
by Takemura et al. (2001), the results revealed that breastfeeding significantly 
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increased the risk for asthma; yet data was collected retrospectively and 
information to complete the questionnaires was supplied exclusively from 
parental report. As part of a prospective study conducted on a group of subjects 
from Britain, Lewis et al. (1996) reported that breastfeeding did not result in a 
decreased incidence of wheezy bronchitis or asthma at the age of 16; however, 
asthma and wheezing were once again based on parental report.  
On two occasions, Wright, Holberg, Taussig, and Martinez (2000 & 
2001b) reported no protective effect between breastfeeding and incidence of 
asthma in childhood. In this earlier study, the researchers found no significant 
relationship between the length of exclusive breastfeeding and the number of 
cases of physician diagnosed asthma by the age of 11 years among children with 
non-asthmatic mothers. Among the children with asthmatic mothers, there was a 
significantly higher rate of asthma by 11 years of age the longer the children were 
exclusively breastfed as infants. More recently, Wright, Holberg, Taussig, and 
Martinez (2001b) noted that exclusive breastfeeding for at least four months 
reduced the frequency of recurrent wheezing in the first few years of life despite a 
maternal history of asthma or the presence of atopy in the child. Wright et al. 
(2001b) did go on to notice, though, that exclusive breastfeeding greater than four 
months increased the risk of asthma and recurrent wheezing between the ages of 
six and 13 years in atopic children born to asthmatic mothers. Nonetheless, as 
Peat and Li (1999) noted in a review about potential causes of asthma, it is not 
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clear if interventions, such as promoting breastfeeding, will reduce the prevalence 
of asthma in the long run; however, there is strong enough evidence to support the 
theory that a reduction in asthma occurrence in the short term is possible and any 
measures to possibly decrease the incidence of this disease are important while 
more studies are being conducted.  
Exclusivity of breastfeeding  
 One reason for the discrepancies surrounding the protective effects of 
breastfeeding is because of the fact that different studies use different terms to 
define breastfeeding. Some studies may consider breastfeeding to include any 
amount of breast milk regardless of supplementation with formula. Other studies 
divide subjects into groups receiving only breast milk, a combination of breast 
milk and formula, and no breast milk. As Bauchner et al. (1986) noted, many of 
the problems inherent with early studies regarding breastfeeding and illness were 
due to the fact that breastfeeding was not well defined. For example, a study by 
Pullan et al. (1980) failed to show an association between breastfeeding and 
reduction in hospital admissions for RSV after controlling for extraneous 
variables. However, the study failed to provide a definition of the term 
breastfeeding. Additionally, Dewey et al. (1993) found no significant relationship 
between breastfeeding and respiratory illnesses, although they did not base 
breastfeeding entirely on exclusivity and studied a group primarily with mild 
upper respiratory illnesses instead of more severe lower respiratory tract illnesses. 
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Similarly, the studies by Fergusson et al. (1981) and Taylor et al. (1982) failed to 
show an association between breastfeeding and respiratory illnesses after 
controlling for socioeconomic factors, but did not classify feeding groups 
according to exclusivity.  
Another study by Margolis et al. (1992) found that breastfeeding, when 
examined in conjunction with other risk factors for respiratory problems, did not 
result in reduced occurrence of respiratory illnesses. Then again, breastfeeding 
was defined as receiving any breast milk, despite the amount of formula given. 
The study by Rubin et al. (1990), described previously, also found no significant 
association between breastfeeding and illness. Yet, the researchers used mixed 
feeding groups when drawing conclusions.  
The outcomes of previous studies could have potentially been influenced 
by the lack of a clear definition of breastfeeding (Kovar et al., 1984). In some of 
the studies in which breastfeeding has been categorized based on exclusivity, 
significant protective effects of breastfeeding have resulted. For example, Raisler 
et al. (1999) classified infants based on varying doses of breast milk that they 
received and found that exclusive breastfeeding was associated with a reduction 
in cough, wheezing, vomiting, and diarrhea during the first six months of life 
while minimal breastfeeding was not. The inverse relationship remained while 
controlling for socioeconomic conditions. When Cesar et al. (1999) examined the 
relation between infant feeding and hospital admission for pneumonia, an inverse 
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relationship was found between incidence of pneumonia and exclusivity of 
breastfeeding, especially during the first three months of life. In a study by Wright 
et al. (1998), it was determined that exclusive breastfeeding reduced incidence of 
bronchiolitis, pneumonia, and croup. Finally, in an extensive review by 
Cunningham et al (1991), it was also noted that protection from breastfeeding 
increased relative to the exclusivity of breastfeeding, further substantiating the 
necessity of defining breastfeeding based on exclusivity to optimize outcomes.  
Extraneous Variables  
 Due to ethical issues, it is impossible to set up an experiment on infant 
feeding by randomly assigning the infants to various feeding groups and then 
drawing definitive conclusions from the study. However, by not randomly 
assigning infants to feeding groups, causality may not be derived from the results, 
and the results may be falsely negative or positive based on other socio-
demographic or physical characteristics. Thus, in addition to the necessity of 
distinguishing between exclusive and partial breastfeeding, it has been well 
recognized that the way to strengthen the results of studies on infant feeding is to 
control for potential variables that may confound the benefits of breastfeeding in 
relation to respiratory illnesses and various other diseases. As noted by Takemura 
et al. (2001), “Many risk factors for asthma have been proposed including age, 
gender (male), smoking and family history of asthma” (p.115). Additionally, in a 
report detailing the 12 necessary standards of infant feeding and illness studies, 
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age ranges of the infant, ethnic origin, family history of atopic disease, and smoke 
exposure were listed as the largest sources of confounding variables in infant 
feeding studies (Kramer, 1988).  
Sex of the child is considered a confounding variable due to its well- 
documented association with respiratory illnesses. As a matter of fact, when 
considering the effects of sex of the child on the outcome variable, Burr et al. 
(1993), Rylander et al. (1993), and Takemura et al. (2001) established that both 
wheezing and asthma occurred more frequently in boys than in girls. A 
significantly higher prevalence of atopic disorders, such as asthma, in males from 
birth to seven years of age has also been reported by Zeiger & Heller (1995). In 
addition to asthma, it has been found that boys experience lower respiratory tract 
infections more often than girls (Nafstad et al., 1996). Holberg et al. (1991) 
reported that males had significantly more RSV positive lower respiratory 
illnesses in the first one to three months of life than females. Their speculation in 
regards to this discrepancy was that “Males are likely to have smaller airways for 
their lung size than females.” (Holberg et al., 1991, p. 1149). Thus, when lungs 
are still developing during the first few months of life, males may be at a 
disadvantage due to this structural difference and any possible benefits of 
breastfeeding may be masked by this difference. 
 On top of controlling for sex, researchers have also agreed that it is vital to 
control for ethnicity of the child. In a study conducted by Zeiger and Heller 
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(1995), the prevalence of atopy was reported to be higher among the non-white 
population. The rate of RSV positive lower respiratory illnesses was also found to 
be significantly higher among the Hispanic population in the first one to three 
months of life (Holberg et al., 1991). In fact, Wright et al. (1989) even found that 
being a male and of Hispanic origin intensified the protective effects of 
breastfeeding even more. Additionally, asthma prevalence is found to be higher 
among African American children, even among those of higher socioeconomic 
status (Morgan & Martinez, 1992).  
While conducting a study using data gathered from the National Survey of 
Family Growth, Forste, Weiss, and Lippincott (2001) discovered that African 
Americans were 2 ½ times less likely to breastfeed than Caucasian women, and 
that this lack of breastfeeding contributes to the higher infant mortality rate 
among African American infants. Thus, according to that study, the effects of 
breastfeeding may actually become increasingly beneficial, rather than masked, 
when accounting for ethnicity of the child. If rates of respiratory illnesses are 
noted to be higher among the non-white population, and the protective effects are 
more pronounced in certain ethnic groups, the actual role of breastfeeding in 
relation to respiratory illnesses may be slanted. 
As well as ethnicity of the child possibly skewing the benefits of 
breastfeeding in a positive or negative manner, researchers have also found that 
parental history of allergy and asthma may impact the profitable aspects of 
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breastfeeding. In fact, one of the risk factors for wheezing illnesses and asthma is 
a parental history of atopic disease (Burr et al., 1993; Takemura et al., 2001), 
particularly if maternal asthma is present (Litonjua, Carey, Burge, Weiss, & Gold, 
1998; Martinez et al., 1995; Wright et al., 2000; Wright et al., 1995) and the child 
is greater than 18 months of age (Rylander et al., 1993). The incidence of 
maternal asthma has been shown to triple the risk for asthma in children less than 
five years of age when compared to paternal asthma (Litonjua, Carey, Burge, 
Weiss, & Gold, 1998). Furthermore, Porro et al. (1993) reported that “the greatest 
influence on wheezing is exerted by a positive family history of atopy and that a 
mother’s positive history alone has the same value” (p. 24). Another important 
reason to differentiate between maternal and paternal atopic status is due to the 
notion that breast milk composition may be affected by atopy (Wright et al., 
1999). 
Due to the strong evidence that family history of atopic disease, 
particularly maternal history of atopy, has on infants and children, numerous 
studies have been conducted in recent years on breastfeeding and maternal and 
child IgE levels. Once again, increasing IgE levels often serve as an indicator of 
various atopic conditions. If there is a maternal history of allergy and 
allergy/asthma, it has been hypothesized that this may actually negate some of the 
protective effects of breastfeeding. For instance, Wright, Sherrill, Holberg, 
Halonen, and Martinez (1999) found that as maternal levels of IgE increased, so 
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did infant IgE levels, especially in those infants breastfed greater than four 
months. When the IgE levels of the children were tested at ages six and 11, IgE 
levels remained significantly higher among this group. Infants who were breastfed 
less than four months did not exhibit elevated IgE levels. Among the infants of 
mothers with low IgE levels, breastfeeding greater than four months was not 
associated with higher IgE levels during childhood. The researchers observed no 
relation between paternal IgE and child IgE levels. In a study published in 1995, 
Wright et al. found that recurrent wheezing, defined as four or more episodes in 
the past year, was significantly decreased at six years of age in non-atopic 
children who were breastfed during infancy for any period of time regardless of 
presence of wheezing during infancy. These results did not hold true for atopic 
children, however. In a more recent study by Wright, Holberg, Taussig, and 
Martinez (2001b), it was discovered that atopic children who were exclusively 
breastfed by asthmatic mothers had a higher risk of asthma and persistent wheeze 
after six years of age but a lower risk of wheeze through two years of age, despite 
maternal atopy or asthma. Thus, breastfeeding may offer some initial protection, 
but that protection may decrease with age.  
On a different note, Duchen and Bjorksten (1996) reported low levels of 
IgE in colostrum, and found the levels to be similar between atopic and non-
atopic mothers. They concluded that the low IgE levels found in colostrum most 
likely do not have a significant relationship to the IgE levels of the infant. To help 
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clarify these conflicting results in regard to IgE levels in mothers, breast milk, and 
children, Peat, Allen, & Oddy (1999) posed an alternate explanation stating that 
atopic mothers may produce breast milk that is composed of different nutrients 
than that of a non-atopic mother. For example, omega-3 fatty acids, which play a 
role in reducing inflammation, are reduced in highly allergic mothers. Once again, 
after considering these abovementioned findings, it becomes necessary to control 
for this maternal history of allergy and/or asthma in order to provide further 
clarification regarding the valuable aspects of breastfeeding. 
Finally, on top of family history of allergy and asthma confounding any 
protective effects of breastfeeding, there is a strong belief that smoke exposure 
may counteract any benefits that breastfeeding confers. In fact, there does appear 
to be an increase in respiratory illnesses among children that are exposed to a 
smoke-filled environment (Peat & Li, 1998). Strachan (1992) noted that “the most 
remedial cause of chest illness in the first year of life currently is parental 
(particularly maternal) smoking” (p. 178). Smoking in the household has also 
been shown to be significantly associated with wheezing in the early years of life 
(Burr et al., 1993; Martinez et al., 1995; Porro et al., 1993; Rylander et al., 1993; 
Stoddard & Miller, 1995) as well as asthma later in life (Martinez, Cline, & 
Burrows, 1992). Additionally, it has been reported that infants of mothers who 
smoked during pregnancy have smaller lungs and diminished lung function (Gern, 
Lemanske, & Busse, 1999). “Maternal smoking seems to modify lung 
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development so that the infant will have diminished lower airway function and, as 
a result, be at increased risk for developing wheezing upon viral infection of the 
bronchial tree” (Morgan & Martinez, 1998, p. 689). Finally, Becker et al. (1999) 
also discussed the fact that tobacco smoke exposure is correlated with an 
increased risk of respiratory illnesses, diminished lung function, and bronchial 
hyperresponsiveness. 
In addition to smoking leading to increased rates of respiratory illnesses 
among children, it may also have an impact on breast milk. Lawrence (2001) 
found that cigarette smoking might actually decrease levels of breast milk 
produced. This could possibly decrease an infant’s exposure to the beneficial 
compounds found in breast milk as well as affect their nutritional status and 
subsequent growth and development. 
Some researchers, on the other hand, have found that breastfeeding may 
actually bestow supplementary protection on infants exposed to smoke in their 
environment. Nafstad et al. (1996) reported that infants who were breastfed longer 
than six months did not have a higher risk of lower respiratory tract infections. 
Thus, the researchers felt that the outcomes did not back previous beliefs that by 
products of tobacco smoke are passed to the child through breast milk and cancel 
out any protective effects. In fact, breastfeeding was more protective among 
infants of smoking mothers than non-smoking mothers. On top of that, Holberg et 
al. (1991) observed that smoking had no correlation with the frequency of RSV 
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positive lower respiratory tract infections during the first 12 months of life. 
Likewise, Takemura et al. (2001) reported no significant difference in rates of 
asthma among children with and without parents who smoke. Finally, Woodward, 
Douglas, Graham, and Miles (1990), reported that although maternal smoking 
resulted in a greater risk for respiratory illnesses during the first year of life, this 
risk was seven times higher in those infants who were not breastfed. In summary, 
since it appears that smoking may or may not reduce or strengthen the protective 
effects of breastfeeding, it is important to control for it during the statistical 
analysis due to some inconsistencies on its influence that have been reported 
previously. 





The purpose of this study was to determine if there is a relationship 
between the incidence of RSV positive wheezing illnesses during infancy among 
the infants participating in the COAST study due to the length of exclusive breast 
or formula feeding. Extraneous variables such as gender of the infant, maternal 
history of allergy and/or asthma, smoke exposure, and ethnicity of the infant are 
also thought to play a role in the development of respiratory illnesses. These 
variables were examined in addition to breastfeeding to determine if they have an 
effect on the incidence of RSV positive wheezing illnesses, and negate, mask, or 
amplify any protective effects of breastfeeding. 
  Data utilized for this study on factors affecting RSV positive wheezing 
illnesses in the first year of life was obtained from the COAST project that began 
in October 1998. This subsidiary study received approval by the Institutional 
Review Board at the University of Wisconsin-Stout, Menomonie, Wisconsin. 
Approval for the COAST project was granted by the Institutional Review Boards 
at University of Wisconsin-Madison, Meriter Hospital in Madison, WI, and St. 
Mary’s Hospital Medical Center in Madison, WI. Re-approval was granted when 
the original documents expired in 2001.  
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Subjects 
 The subjects for this project included the 287 infants participating in the 
COAST study that were at least one year of age by May 2001. All of the infants 
were recruited from one of the following hospitals in south central Wisconsin: 
Meriter, St. Mary’s, UW Hospital, Baraboo, Fort Atkinson, Portage, and 
Reedsburg. Subjects were enrolled in the COAST study at birth. To be eligible for 
study entry, at least one of the biological parents had to have allergies (defined as 
one or more positive allergy skin tests to aeroallergens), asthma or both. Informed 
consent was obtained from the parents or guardians of the infants prior to their 
enrollment in the study. A copy of the informed consent document was provided 
to the University of Wisconsin–Stout and is located in Appendix A. 
In order to protect their confidentiality, the subjects were given an 
identification number upon enrollment in the study at birth. Additionally, in the 
original study’s Patient Information and Consent Form, a section entitled 
“Voluntary Participation/Withdrawal from Study” explains the fact that 
participation is voluntary and subjects can withdraw from the study at any point in 
time. Parents signed the form as subjects were less than one year of age.  
Since RSV is epidemic in nature and occurs more frequently during 
certain seasons, subjects were recruited on a quarterly basis with approximately 
40 subjects each quarter. All subjects were required to have an Apgar score over 
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six at five minutes of age, to be born between 38 and 42 weeks of gestation, and 
to be free of birth defects or illnesses at birth. This eligibility requirement 
eliminated the possibility of seriously ill children from confounding the results as 
they may be more prone to respiratory illnesses.  
Parents of subjects were self-selected and learned of the study through 
several means: newspaper, radio, and/or television advertisements; brochures 
obtained from LaMaze classes, local obstetric, family practice, pediatric, 
immunization, and/or women’s clinics; letters mailed to families in the 
community informing them of upcoming studies; community baby supply retail 
stores; pharmacies; health fairs; word of mouth. The subjects were representative 
of the Madison area community. Of the study population, approximately 56% 
were male and 44% female. According to the Wisconsin Department of Health 
and Human Services (2000), about 51% of the population in the zero to fourteen 
years age bracket in the Madison area community is male and 48% is female. The 
ethnic distribution of the subjects was as follows: 87% Caucasian, 8% African 
American, 3% Hispanic/Latino, 1% Asian/Pacific Islander, and 1% American 
Indian/Eskimo. This is similar to the ethnic distribution of the Madison area 
community which is roughly 89% Caucasian, 4% African American, 3% 
Hispanic, 4% Asian/Pacific Islander, and 0.3% American Indian/Eskimo 
according to the U. S. Census Bureau (2000). 
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Procedures 
Data utilized for this secondary study was obtained from several different 
questionnaires designed specifically for the COAST study by a group of 
physicians and their associates at University of Wisconsin Asthma and Allergy 
Clinical Research Unit in Madison. A paper copy of all the questionnaires and 
original data was kept in individual subject binders in the COAST laboratory. 
There was one binder for each subject. It was labeled on the outside with subject 
identification number only. The majority of the data for this study was obtained 
from the computerized COAST database, however. The paper copy of the 
questionnaires was utilized only when a certain piece of information was missing 
on a subject from the computerized database. This occurred in nine different cases 
in regard to feeding history.  
Entry of information into the computerized database was completed by 
COAST research assistants. Consent was granted before accessing the 
computerized database to protect all subjects since they can be identified by both 
name and identification number in the computer. However, no names were 
utilized in this study, only identification numbers. 
Table I lists the source, question number, and an abbreviated (i.e. only the 
questions utilized from the questionnaires are listed) version of the 
questions/items utilized in this study  to determine the following variables: infant 
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feeding history, sex of the infant, ethnicity of the infant, smoke exposure, 
maternal history of allergy and/or asthma, and RSV positive wheezing illnesses. 
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Table 1: The COAST documents and a shortened version of questionnaire 
items utilized to define variables in the study 
VARIABLE DOCUMENT QUESTION 
NUMBER 
QUESTION 
Feeding history Data Base Additions March, 
2000 
# 1 item 17 Did not breastfeed (i.e. this item was checked if the 
mother did not ever breastfeed)  
  # 3 items 1-12 At what age (in months) did you start supplementing 
with formula: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 
  # 3 item 13 Never used formula 
Sex of the child Child Questionnaire One A items 1 and 2 Sex of your child: male or female 
Ethnicity Personal Data Form 1/9/99 # 16 item 1-5, 
99 
Race: Mother – Caucasian, African American, 
Asian/Pacific Islander, American Indian/Eskimo, 
Hispanic/Latino, Other 
  # 25 item 1-5, 
99 
Race: Father – Caucasian, African American, 
Asian/Pacific Islander, American Indian/Eskimo, 
Hispanic/Latino, Other 
Smoke Exposure Parent Questionnaire 1 # 45 item b 
 
# 47 
If you started smoking cigarettes at a certain age, do you 
still smoke? 
Do you smoke a pipe or cigar? 
 Parent Questionnaire 2-10 
(same questionnaires 
completed at visits 2-10) 
# 46 
# 47 
Has there been a change in your smoking status? 
Do you now smoke a pipe or cigar? 
 Child Questionnaire 2-9 
(same questionnaires 





Does the child’s mother smoke? 
Does the child’s father smoke? 
How many people who live in the child’s home smoke? 
Does anyone who cares for the child smoke? 
 Daycare  Questionnaire # 4 Is child exposed to passive smoke while at day care? 
 Residential Questionnaire # 4 Is child exposed to passive smoke in your home? 
Maternal History of 
Allergy and/or 
Asthma 
Allergy Skin Test Form # 2-13 Have you had a positive allergy skin test to any of the 
allergens listed? 
 Data Base Additions 
November, 1999 
# 5 Has your asthma diagnosis been confirmed by an MD. If 
yes, provide date and name of MD. 
 Parent Questionnaire 1 # 1   
#2   
# 4 
Have you ever had allergies or asthma ? 
Have you ever had an asthmatic attack? 
Was asthma confirmed by a doctor? 
 Parent Questionnaire 2-10  # 1  
# 4 
Have you developed allergies or asthma ? 
Was asthma confirmed by a physician? 
Wheezing Status Respiratory Illness History # 4 and # 3, 7, 
8, 9, 11, or 12 
Parental report that child has used bronchodilators, 
prednisone, or asthma controllers 
 Respiratory Illness 
Assessment 
#5 item j 
#8 item a, d, f, g 
#9 item d, e, h, i 
Symptomatic for wheezing 
Indicate treatment options for respiratory illnesses 
Indicate bronchiolitis, wheezing illness, reactive airway 
disease, or asthma 
 Childrens’ Questionnaire 
Source Document 
# 10 
# 11 item 2 
Indicates treatment options for respiratory illnesses 
Wheezing on inspiration or expiration 
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Infant Feeding History 
One questionnaire was designed to collect information regarding length of 
exclusive breastfeeding or formula feeding for each infant. When infants were one 
year of age, their parents filled out the questionnaire in the presence of a COAST 
nurse stating the age in months that breastfeeding was supplemented with any 
amount of formula (one month, two months, three months, and so forth until 
twelve months of age). Thus, from this question it is possible to derive when 
exclusive breastfeeding was stopped. If breastfeeding was never initiated, parents 
checked “did not breastfeed.” If formula was never used, parents checked “never 
used formula.” An abbreviated copy of the questionnaire can be found in 
Appendix B.  
The feeding data being analyzed in this study was collected 
retrospectively. Although feeding data was collected retrospectively, this method 
meets Kramer’s (1988) standards as it did not rely “on prolonged maternal recall” 
(p. 182) since it was collected at one year of age. Furthermore, Wright et al. 
(2001) found over 90% agreement after comparing infant feeding data collected 
both prospectively and retrospectively in their most recent published study.  
Subjects were divided into three groups and data was analyzed separately 
for each group. The groups were based on feeding history as follows:  1) never 
breastfed (i.e. only formula), 2) exclusively breastfed (i.e. no formula) less than 
six months, or 3) exclusively breastfed (i.e. no formula) greater than or equal to 
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six months. The exclusively breastfed infants were divided into two groups at the 
six-month period since only about 20% of the population still breastfeeds at this 
six month point (Abbot Laboratories, 2001). Thus, it was important to determine 
whether breastfeeding in the early months of life, when it is the most common 
time to employ this method of feeding, was more, equally, or less beneficial as 
breastfeeding for six months or longer, defined by Saarinen and Kajosaari (1995), 
as “prolonged breastfeeding” (p. 1066). Moreover, there has been some 
controversy over whether or not breastfeeding is only protective during the period 
of utilization and in the earlier months of life or whether the effects extend 
beyond that early period. Additionally, six month intervals help provide adequate 
time to reap any protective effects of breastfeeding as recommended by Kramer 
(1988). Finally, it was important to base the feeding categories on exclusivity 
because the length of exclusive breastfeeding is a better predictor of the 
dependent variable than breastfeeding in general (Oddy et al., 1999). 
Sex of the Infant 
The sex of the infant, classified as either male or female, was obtained 
from a questionnaire that was completed at the infant’s first check-up two months 
after birth. An abbreviated copy of the form can be found in Appendix C. 
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Ethnicity of the Infant 
The ethnicity of the infant was derived from information on the ethnic 
background of his or her parents. Parents had the option of selecting one of the 
following races: Caucasian, African American, Asian/Pacific Islander, American 
Indian/Eskimo, Hispanic/Latino, or Other. If each parent was of a different ethnic 
background, the child’s ethnicity was listed as the minority race. For example, if 
the child’s mother was Caucasian and the child’s father was African American, 
the child would be listed as an African American. Since approximately 90% of the 
subjects were Caucasian, they were classified as Caucasian or non-Caucasian for 
analytical purposes rather than grouped into separate categories for each 
individual race.  Of the 287 infants in the study, parents provided complete 
information to classify the race/ethnicity of 282 subjects. An abbreviated copy of 
the form used to determine ethnicity can be found in Appendix D. 
Smoke Exposure 
For a subject to qualify as having been exposed to smoke in the 
environment, a parent would have to have smoked at any time during the child’s 
life, a mother would have to have smoked during pregnancy, or the subject would 
have to be exposed to smoke on a regular basis outside of the home, such as in 
daycare. For analytical purposes, subjects were labeled as having a positive or 
negative history of environmental smoke exposure. This method was preferred 
over categorizing the subjects as positive to maternal smoking, paternal smoking, 
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or smoke outside of the home since the percentage of subjects falling into each of 
these individual categories was quite small. Useable responses on smoke exposure 
were obtained for 284 of the 287 infants in the study . An abbreviated copy of 
each of the forms utilized to determine if the child was exposed to smoke is 
located in Appendix E. 
Maternal History of Allergy and/or Asthma 
Maternal history of allergy was determined based on a positive response to 
the allergy skin test form. Maternal history of allergy as well as asthma was also 
ascertained from questions about the development of allergy and asthma, the 
diagnosis of asthma by a physician, and the presence of asthmatic attacks. The 
total number of infants included in the analysis of maternal history of allergy 
and/or asthma was less than 287 because not all of the mothers stated if they had a 
history of asthma and/or allergies or not. Abbreviated copies of each 
questionnaire can be found in Appendix F. 
RSV and RSV Positive Wheezing Illnesses 
The number and type of RSV positive or negative respiratory illnesses 
each infant experienced was obtained from the COAST database. The respiratory 
illness data was collected prospectively. The infant’s age in months was also 
documented when the illness was diagnosed. The following protocol for 
collecting virus data was designed prior to the start of the COAST study by a 
group of physicians and their associates at University of Wisconsin Asthma and 
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Allergy Clinical Research Unit in Madison. Diagnosis of a RSV positive illness 
was based on the following procedure:  
Parents were provided with the phone number and pager number of 
COAST personnel. They were instructed to phone the clinic at the first sign of a 
lower respiratory tract illness (such as wheezing, coughing, chest rattling, and 
fever). The COAST personnel then reviewed the signs and symptoms using a 
virus severity scorecard. On the scorecard, each symptom of a respiratory illness 
is listed along with a point value according to the severity of the symptom. For 
example a child with a fever receives one point, a severe cough three points, or 
wheezing five points.  
A child scoring greater than or equal to a score of five was presumed to 
have a respiratory illness. If the child was thought to have a respiratory illness, he 
or she was instructed to come to the clinic for a physical exam at which point a 
nasopharyngeal mucus sample and throat swab were taken to confirm or reject a 
diagnosis of a RSV positive illness. The RSV positive status was determined by 
analysis of the samples sent to the Wisconsin State Laboratory of Hygiene, 
Madison, Wisconsin.  
Well-child visits were conducted at two, four, six, nine, and twelve 
months of age at which time nasopharyngeal mucus testing was done to detect the 
presence or absence of respiratory viral pathogens. The sample was analyzed by 
the Wisconsin State Laboratory of Hygiene. The person making the diagnosis of 
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RSV illnesses was not aware of the child’s feeding history. This meets Kramer’s 
(1988) standard of “blind ascertainment of feeding history” (p. 182). 
When studying the respiratory illness data, it was necessary to distinguish 
RSV positive wheezing illnesses from RSV positive illnesses in general, 
regardless of the presence of wheezing, among those infants who experienced an 
RSV positive infection during infancy. The necessity of determining whether or 
not the illness occurred in association with wheezing was due to the notion that 
analyzing respiratory illnesses both with and without wheezing together may 
mask any protective effects of breastfeeding (Wright et al., 1989). Additionally, 
wheezing helps determine the severity of the illness, not just its occurrence. 
Several different factors were considered to determine if a physician 
diagnosed wheezing illness occurred. The child was recorded as having a 
wheezing illness if he or she used bronchodilators, prednisone, or asthma 
controllers, experienced wheezing on inspiration or expiration, or experienced 
bronchiolitis, reactive airway disease, or asthma. Abbreviated copies of all 
questionnaires that helped determine the diagnosis of RSV positive illnesses as 
well as wheezing can be found in Appendix G. 
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 Data Treatment and Analysis 
The Statistical Package for Social Sciences (SPSS) version 10.0 was 
utilized for data analysis. The data was entered into a spreadsheet created in SPSS 
and coded into numerical format on the basis of the following: 1). Presence or 
absence of RSV infections during infancy, 2). Presence or absence of wheezing 
with RSV infections, 3). Child’s gender (male or female), 4). Maternal history of 
allergy, asthma, and/or allergy accompanied with asthma, 5). Ethnicity of the 
child (Caucasian or non-Caucasian), 6). Smoke exposure (positive or negative), 
and 7). Infant feeding category (never breastfed, exclusively breastfed less than 
six months, or exclusively breastfed greater than or equal to six months). 
Frequency analyses were conducted in order to determine the percentage 
distribution for each variable studied. The Chi-Square procedure was utilized to 
test the hypothesis that length of exclusive breastfeeding and formula feeding are 
independent of gender, ethnicity, smoke exposure, and maternal history of allergy 
and/or asthma. The Pearson chi-square statistic was employed to determine 
significance of the results. In order to determine if an individual association exists 
between RSV/RSV positive wheezing illnesses and length of exclusive 
breastfeeding, gender, ethnicity, smoking, and maternal history of allergy and/or 
asthma, binary logistic regression analysis was applied. Binary logistic regression 
analysis is useful for determining the odds of an event occurring in the presence 
of certain independent variables. Confidence intervals were also estimated.  
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It was necessary to use binary logistic regression analysis because the 
dependent variable was dichotomous nominal and there was no statement 
regarding the linearity of the relationship between the independent and dependent 
variables. Finally, using multivariate logistic regression analysis, length of 
exclusive breastfeeding, gender, ethnicity, smoke exposure, and maternal history 
of allergy and/or asthma were all factored into the equation using the block entry 
method to determine any associations among variables and RSV/RSV positive 
wheezing illnesses when examined in combination with each other rather than 
separately.  
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CHAPTER 4 
Results 
Population Characteristics  
A study was conducted on a sample of 287 infants to determine the 
relationship, if any, among breastfeeding, gender of the child, ethnicity of the 
child, smoke exposure, and maternal history of allergy and/or asthma in 
conjunction with RSV positive wheezing illnesses. Table 2 presents the 
characteristics of the sample population. Approximately 56% of the subjects were 
male and 44% female. The majority of the population was Caucasian (87%) 
compared to non-Caucasian (13%). Subjects were much more likely to have been 
exclusively breastfed than never breastfed at all. Roughly 43% of the subjects 
were exclusively breastfed for six months or longer, 48% were exclusively 
breastfed for less than six months, and the remaining subjects were never 
breastfed. Additionally, subjects were much less likely to be exposed to smoke in 
their environment (76%). Only one-fourth of the population (24%) came into 
contact with smoke on a routine basis. Many of the subjects had mothers with a 
history of allergies alone (47%) or allergies in conjunction with asthma (37.6%). 
Subjects without a maternal history of allergy and/or asthma comprised about 
12% of the study population although they did have a paternal history of allergy 
and/or asthma. The remaining subjects had a maternal history of asthma alone. 
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TABLE 2: Population Characteristics 
 
Characteristic       Infants    
        n (%) 
Feeding Method (N=287) 
 Never Breastfed     26  (9.1%)   
 Exclusively Breastfed < 6 months   139  (48.4%) 
 Exclusively Breastfed ≥ 6 months   122  (42.5%) 
Gender of child (N=287) 
 Male       162  (56.4%) 
 Female      125  (43.6%) 
Ethnicity of child (N=282) 
 Caucasian      245  (87%) 
 Non-Caucasian     37  (13%) 
Smoke Exposure (N=284) 
 Positive      68  (24%) 
Negative      216  (76%) 
Maternal History (N=276) 
 Allergy      130  (7%) 
 Allergy and Asthma/Asthma alone   114  (41.5%) 
 Neither        32  (11.5%) 
Presence of RSV (N=287) 
 Positive      102  (35.5%) 
 Negative      185  (64.5%) 
Presence of RSV with Wheezing (N=102)    
 Positive      45  (44.1%) 
 Negative      57  (55.9%) 
 
N = less than 287 due to missing data for this category
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      The presence of RSV was detected in about one-third of the subjects 
during infancy while the remaining subjects did not have an RSV positive illness. 
This finding is lower than the average occurrence of RSV in infants which is 
around 60% (Glezen et al., 1986 & Openshaw, 1995). Of the subjects in this study 
who experienced an RSV positive illness, approximately 44% had physician 
diagnosed wheezing with the illness, indicating greater severity of the illness, 
while 56% did not have wheezing with RSV. 
Factors Associated with Breastfeeding 
 Certain factors are thought to be associated with breastfeeding during 
infancy. Results of this study showed that breastfed infants were significantly     
(p = 0.043) less likely to have come in contact with smoke than infants who were 
exclusively formula fed. No significant associations (p > 0.05) were found 
between method of infant feeding and, gender, race, and maternal history of 
allergy and/or asthma. A tendency toward an association was observed between 
race of the infant and method of feeding. Non-Caucasian infants seemed more 
likely than Caucasian infants to have never been breastfed or exclusively 
breastfed for a shorter period of time (Table 3). 
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TABLE 3: Factors Associated with Breastfeeding 
 
Characteristic                Length of Exclusive Breastfeeding              P Value of X² 
                                       Never       <6 mos      ≥ 6 mos             
      N = 26 N = 139           N = 122 
        n (%)       n (%)        n (%) 
Gender of Child             
Male                     11 (42%)          78 (56%)          73 (60%)            0.260         
Female                  15 (58%)          61 (44%)          49 (40%) 
Ethnicity of Child 
Caucasian             21 (80%)         117 (84%)         112 (92%)         0.106 
Non-Caucasian       5 (20%)           22 (16%)           10 (8%) 
Smoke Exposure 
Positive                  9 (35%)           38 (27%)           19 (16%)        †0.043 
Negative               17 (65%)         101 (73%)         103 (84%) 
Maternal History 
Allergy                15 (56%)           70 (50%)           56 (46%)        0.615 
Asthma/Allergy      9 (36%)           50 (36%)           54 (44%) 
Neither                    2 (8%)             19 (14%)           12 (10%) 
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RSV Illnesses 
Binary logistic regression analysis was used to examine the individual 
association among infant feeding method, gender, ethnicity, smoking, and 
maternal history of allergy and/or asthma on the occurrence of RSV in infants. 
Using exclusive breastfeeding greater than or equal to six months as the reference 
category, no significant relationship (p > 0.05) was found between presence of 
RSV and never breastfeeding or exclusive breastfeeding less than six months. 
However, those infants who were never breastfed tended to have higher odds of 
contracting RSV. Additionally, no significant association (p > 0.05) was found 
between presence of RSV and sex of the infant, ethnicity of the infant, smoke 
exposure, maternal history of allergy, and maternal history of neither allergy nor 
asthma. In the latter two cases, maternal history of both allergy and asthma was 
used as the reference category. Although non-significant, there was a trend for 
infants exposed to smoke to have more RSV infections as well as a trend for 
infants of non-Caucasian origin to have fewer RSV infections (Table 4). 
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TABLE 4: RSV Illnesses 
 
Characteristic    °OR  °95% CI Significance 
 
Feeding Method 
 Never Breastfed  1.575  0.669-3.706  0.298 
 Breastfed < 6 months  0.939  0.563-1.565  0.808 
 *Breastfed ≥ 6 months  
Gender of Child 
 *Male  
 Female   1.102  0.677-1.793  0.695 
Ethnicity of Child 
 *Caucasian 
 Non-Caucasian  0.616  0.285-1.331  0.218 
Smoke Exposure 
 Positive   1.434  0.817-2.517      0.210 
 *Negative 
Maternal History 
 Allergy   1.118  0.661-1.893  0.677 
 *Asthma/Allergy 
 Neither   1.053  0.467-2.370  0.901 
 
°OR=Odds ratio, CI=Confidence Interval 
*Served as reference category in the analysis 
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RSV Positive Wheezing Illnesses 
No significant connection (p > 0.05) was found between RSV positive 
wheezing illnesses and never breastfeeding or exclusive breastfeeding less than 
six months when using exclusive breastfeeding six months or longer as the 
reference category. Furthermore, no significant association (p > 0.05) was found 
between sex of the child, ethnicity of the child, and maternal history of neither 
allergy nor asthma (Table 5).  
There was, however, a significant relationship (p = 0.036) between RSV 
positive wheezing illnesses and maternal history of allergy alone compared to a 
history of both allergy and asthma. Infants of mothers with both allergies and 
asthma compared to mothers with allergies alone were more likely to get RSV 
positive wheezing illnesses during infancy. Although contradictory to the majority 
of the available research, there was a weak inverse trend between RSV positive 
wheezing illnesses and smoke exposure. Infants exposed to smoke appeared to 
have fewer RSV positive wheezing illnesses (Table 5).  
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TABLE 5: RSV Positive Wheezing Illnesses 
 
Characteristic    °OR  °95% CI Significance 
 
Feeding Method 
 Never Breastfed  0.695  0.181-2.664  0.595 
 Breastfed < 6 months  1.331  0.579-3.062  0.501 
 *Breastfed ≥ 6 months  
Gender of Child 
 *Male  
 Female   0.954  0.435-2.093  0.906 
Ethnicity of Child 
 *Caucasian 
 Non-Caucasian  0.829  0.219-3.136  0.783 
Smoke Exposure 
 Positive   0.500  0.200-1.248  0.138 
 *Negative 
Maternal History 
 Allergy   0.397  0.167-0.940  †0.036 
 *Asthma/Allergy 
 Neither   0.519  0.139-1.937  0.329 
 
°OR=Odds ratio, CI=Confidence Interval 
*Served as reference category in the analysis 
†p < 0.05 
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 Multiple Logistic Regression Analysis and RSV Illnesses 
 Multiple logistic regression analysis was utilized to find an association 
between  feeding method, gender, ethnicity, smoke exposure, and maternal history 
of allergy and/or asthma in conjunction with RSV positive illnesses. All of the 
causal variables were entered into the equation in one step. There was no 
significant relationship (p > 0.05) between presence of RSV and gender of the 
infant, ethnicity of the infant, maternal history of allergy, maternal history of 
neither allergy nor asthma, never breastfeeding, or exclusive breastfeeding less 
than six months. However, when examining the odds of developing RSV after 
comparing never breastfeeding to exclusive breastfeeding greater than or equal to 
six months, those infants who were never breastfed seemed more likely to get 
RSV.  Also, there was a tendency toward an association between smoke exposure 
and presence of RSV and ethnicity of the infant and presence of RSV. Infants 
exposed to smoke tended to have more RSV infections than those not exposed to 
smoke. Infants of non-Caucasian origin tended to be less inclined than Caucasian 
infants to have RSV (Table 6).  
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TABLE 6: Multiple Logistic Regression Analysis and RSV Illnesses 
 
Characteristic    °OR  °95% CI Significance 
 
Feeding Method 
 Never Breastfed  1.723  0.697-4.262  0.239 
 Breastfed < 6 months  0.958  0.563-1.628  0.873 
 *Breastfed ≥ 6 months  
Gender of Child 
 *Male  
 Female   1.064  0.639-1.770  0.812 
Ethnicity of Child 
 *Caucasian 
 Non-Caucasian  0.513  0.221-1.191  0.120 
Smoke Exposure 
 Positive   1.664  0.902-3.068  0.103 
 *Negative 
Maternal History 
 Allergy   1.134  0.662-1.943  0.647 
 *Asthma/Allergy 
 Neither   1.022  0.447-2.334  0.960 
 
°OR=Odds ratio, CI=Confidence Interval 
*Served as reference category in the analysis 
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Multiple Logistic Regression Analysis and RSV Positive Wheezing Illnesses  
 Table 7 displays the results when comparing the causal variables with 
RSV positive wheezing illnesses. The findings for infant smoke exposure and 
presence of RSV positive wheezing illnesses were somewhat confusing. Infants 
who were exposed to smoke seemed more likely to get RSV, but less likely to 
have wheezing with the illness. A significant relationship (p = 0.032) did appear 
between RSV positive wheezing illnesses when comparing maternal history of 
allergies alone to maternal history of allergy and asthma. Again, maternal history 
of both allergy and asthma was more indicative of RSV positive wheezing 
illnesses than maternal history of allergy alone. No significant relationship (p > 
0.05) was discovered between maternal history of neither allergy nor asthma and 
RSV positive wheezing illnesses. Furthermore, no significant relationship (p > 
0.05) was found between RSV positive wheezing illnesses and never 
breastfeeding, exclusive breastfeeding less than six months, gender of the infant, 
and ethnicity of the infant (Table 7). 
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TABLE 7: Multiple Logistic Regression Analysis and RSV Positive Wheezing  
Illnesses 
 
Characteristic    °OR  °95% CI Significance 
 
Feeding Method 
 Never Breastfed  0.714  0.174-2.931  0.640 
 Breastfed < 6 months  1.482  0.605-3.632  0.389 
 *Breastfed ≥ 6 months  
Gender of Child 
 *Male  
 Female   1.046  0.450-2.432  0.917 
Ethnicity of Child 
 *Caucasian 
 Non-Caucasian  0.933  0.191-4.568  0.932 
Smoke Exposure 
 Positive   0.425  0.150-1.202  0.107 
 *Negative 
Maternal History 
 Allergy   0.372  0.151-0.917  †0.032 
 *Asthma/Allergy 
 Neither   0.530  0.137-2.043  0.356 
 
°OR=Odds ratio, CI=Confidence Interval 
*Served as reference category in the analysis 
†p < 0.05 
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Exclusive Breastfeeding and RSV/RSV Positive Wheezing Illnesses 
 The majority of the subjects were exclusively breastfed for any amount of 
time (90.9%) during the first year of life. Since the “never breastfed” group was 
so small in sample size, both binary logistic regression analysis and multiple 
logistic regression analysis were conducted after eliminating this category from 
the analysis. This analysis was done in order to determine if breastfeeding would 
show an alternate association with RSV and RSV positive wheezing illnesses. 
Results showed no significant relationship (p > 0.05) between the number of RSV 
positive illnesses experienced by infants who were exclusively breastfed less than 
six months compared to the infants who were exclusively breastfed greater than or 
equal to six months when examining breastfeeding alone with RSV and when 
controlling for the extraneous variables. In terms of RSV positive wheezing 
illnesses, the results were similar. No significant association (p > 0.05) appeared 
between length of exclusive breastfeeding and RSV positive wheezing illnesses. 
These results held true when adjusting for confounding variables (Table 8). 
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TABLE 8: Exclusive Breastfeeding and RSV/RSV Positive Wheezing 
Illnesses  
 
Category     ºOR º95%CI Significance 
 
Presence of RSV     0.939 0.563-1.565 0.808 
Presence of RSV (MLR) ∏   0.945 0.554-1.612 0.836 
 
Presence of RSV with Wheezing   1.331 0.579-3.062 0.501 
Presence of RSV with Wheezing (MLR)† 1.578 0.637-3.906 0.324 
 
°OR=Odds ratio, CI=Confidence Interval 
∏ MLR = Multiple Logistic Regression Analysis 
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CHAPTER 5 
Discussion 
This investigation was carried out to determine if a relationship exists 
between RSV positive wheezing illnesses and breastfeeding during infancy, as 
this is a highly controversial area of research (Kramer, 1988 & Cunningham et al., 
1991). As established by the results, this study demonstrates that  
breastfeeding, even for prolonged periods of time, does not seem to 
protect against wheezing illnesses in infants with a maternal history of allergy 
and/or asthma.  
During infancy, the presence of RSV as well as wheezing illnesses 
associated with RSV among infants who were never breastfed was not 
significantly different from infants who were exclusively breastfed for any 
amount of time. There was a trend for infants to have more RSV positive illnesses 
in general if never breastfed even when controlling for gender of the infant, 
ethnicity of the infant, smoke exposure, and maternal history of allergy and 
asthma. However, these results were not significant, and the trend was not 
repeated when wheezing was taken into consideration. Even after removing the 
small group of infants who were never breastfed from the analysis, no inclination 
was detectable between length of exclusive breastfeeding and RSV positive 
wheezing illnesses. These results are similar to findings from previous studies that 
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did not show a relationship between respiratory illnesses and breastfeeding 
(Dewey et al., 1993; Rubin et al., 1990). 
Additionally, no associations were discovered between infant feeding 
history and gender of the infant or maternal history of allergy and/or asthma. 
There was a slight, non-significant tendency for non-Caucasian infants to have 
never been breastfed or breastfed for shorter periods of time. Although consistent 
with previous findings (Weiss & Lippincott, 2001), the result was not significant. 
There was a significant association between smoke exposure and method of infant 
feeding. Those infants who were exposed to smoke were significantly less likely 
to have been breastfed or were breastfed for shorter periods of time. This finding 
is similar to the results obtained by Piscaine et al. (1994). As found previously, 
those infants who are exposed to smoke tend to acquire greater compensation 
from breastfeeding (Nafstad et al., 1996). Thus, breastfeeding may be particularly 
important in smoke filled environments. Furthermore, although ethnicity and 
smoke exposure were controlled for in the multiple logistic regression analysis, 
the fact that these groups were so small in sample size may have not allowed for 
adequate analysis and may have affected the outcome.  
Since it is unethical to randomly assign infants to a feeding category, other 
factors present among the infants that could not be controlled for in this study 
population may have also confounded the results. For instance, part of the lack of 
association between breastfeeding, RSV, and RSV positive wheezing illnesses 
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may be due to the fact that the outcome variables were being studied among 
infants from an urban, middle to upper class environment. First of all, the 
breastfeeding rates were quite high, even higher than the average for the state of 
Wisconsin. In this study population, approximately 9% of the infants were never 
breastfed and 43% were breastfed greater than or equal to six months. In regards 
to breastfeeding rates for the entire state of Wisconsin, only 22% of infants are 
breastfed after five to six months of age (Wisconsin Breastfeeding Coalition, 
1999). Moreover, the subjects were primarily Caucasian, born into families with a 
high median income and a high level of education. Approximately 73% of the 
mother’s and 70% of the fathers had a college degree or higher. The median 
annual income for this area is ~$50,000 compared to a national average of 
~$37,000 (U. S. Census Bureau, 2000).  
As noted in previous studies, the protective effects of breastfeeding appear 
to be much stronger among infants from developing countries than those from 
industrialized nations (Brown et al., 1989; Cesar et al., 1999; Forman et al., 1984; 
Lopez-Alarcon et al., 1997; Victora et al., 1989). Additionally, breastfeeding has 
been shown to be more beneficial among infants of lower socioeconomic status, 
including low levels of parental education, low income, and unsanitary, crowded 
living conditions, than those of higher socioeconomic status. Several studies have 
initially found an association between breastfeeding and respiratory illness; 
however, that relationship often disappears when socioeconomic status is 
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incorporated into the analysis. (Fergusson et al., 1981; Holberg et al., 1991; 
Margolis et al., 1992; Pullan et al., 1980; Rubin et al., 1990; Taylor et al., 1982).  
There are numerous reasons for this distinction. Often, infants born into 
families of low socioeconomic status are at increased risk of infection just 
because of the environment in which they live (Morgan & Martinez, 1992). For 
example, as income levels decline, access to health care and a clean environment 
may also decrease. These infants may be more likely to live in crowded, 
unsanitary environments and be exposed to pollutants and experience a 
subsequent increase in virus related respiratory illnesses (Morgan & Martinez, 
1992). Less educated mothers may also be less knowledgeable about appropriate 
infant care in general. In an article discussing current statistics on breastfeeding 
rates as well as influences on the decision to breastfeed or formula feed, Wright 
observed that “women with less education and lower household incomes were 
also less likely to breastfeed” (2001a, p. 3). It is also commonly observed that 
women with low levels of education do not prepare infant formula to the 
appropriate concentrations. Thus, if infants from low socioeconomic groups are 
more prone to respiratory illnesses and wheezing (Baker et al., 1997) and are less 
likely to breastfeed, any beneficial effects of breastfeeding would be amplified in 
this group. In fact, Holberg et al. (1991) and Cunningham (1979) found that 
infants of mothers with 12 years of education or less appeared to experience a 
greater benefit from exclusive breastfeeding.  
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Decreased lung function may also share a relationship with low 
socioeconomic status as many mothers in this group do not receive adequate 
prenatal care. As Martinez et al. (1995) pointed out, infants with small airways 
and decreased lung function may be more likely to wheeze during a viral 
infection. If they were breastfed, they may improve lung function through 
adequate nutrition and thereby decrease the risk of wheezing. Therefore, this may 
be another one of the reasons breastfeeding was not protective against RSV 
positive wheezing illnesses in the affluent COAST population. However, lung 
function was not measured among this group of infants so an analysis of this 
factor was not possible.  
The most important determinant in regards to wheezing with an RSV 
positive illness in this study was a maternal history of both allergy and asthma. A 
significant relationship appeared between maternal history of allergy and asthma 
and wheezing with an RSV positive illness during infancy. The results were 
significant both when examining maternal history alone with RSV positive 
wheezing illnesses and when adjusting for feeding method, gender of the infant, 
ethnicity of the infant, and smoke exposure. 
These results are in line with recent studies related to asthma and allergy 
during infancy and childhood and a maternal history of atopy (Wright et al., 
1999). As a matter of fact, although a parental history of allergy and asthma is 
considered one of the possible factors in the etiology of wheezing illnesses and 
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asthma in children (Burr et al., 1993; Porro et al., 1993; Takemura et al., 2001), 
maternal asthma in particular is highly associated with wheezing in children. 
(Litonjua et al., 1998; Martinez et al., 1995; Wright et al., 2000). 
One of the conceivable explanations for the lack of association between 
mode of infant feeding and RSV positive wheezing illnesses might be due to this 
maternal history of allergy and asthma. IgE levels are elevated in mothers with 
allergy and/or asthma. It has been discovered that infants born to mothers with 
high IgE levels also have elevated IgE levels at nine months, six years, and eleven 
years of age when breastfed greater than or equal to four months (Wright et al., 
1999). Therefore, the high IgE levels may predispose the infants to illness. These 
markers of allergic disease might be passed through the breast milk itself making 
breastfed infants more prone to atopic disease. 
In an additional study, Wright et al. (2000) found that infants born to 
asthmatic mothers were more likely to have asthma the longer they were 
exclusively breastfed during infancy. For example, 57% of the infants born to 
mothers with asthma who were breastfed at least four months had asthma by age 
11 compared to 9% of the infants who received formula starting at birth. 
Furthermore, in a more recent study, Wright et al. (2001b) again found that 
breastfed atopic children born to asthmatic mothers were at a greater risk for 
wheezing and asthma by age 6 years.  As noted in an earlier study, a family 
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history of allergy may so greatly bias children to wheeze that the benefits of 
breastfeeding are outweighed (Wright et al., 1995).  
The slight trend between exclusive breastfeeding and decreased incidence 
of RSV positive illnesses but no association between exclusive breastfeeding and 
wheezing illnesses associated with RSV might also be explained by this maternal 
history of allergy and asthma. Since RSV is caused by infection, breastfeeding is 
often thought to confer some protection against it (Wright et al., 1999). However, 
wheezing may be immune to any protective effects of breastfeeding since high 
IgE levels have been found to share an association with the presence of wheezing.  
Although the results of this study may not be generalizable due to the 
characteristics of the study population, several factors were taken into 
consideration to strengthen the validity of the study. Kramer (1988) defined 
several standards to improve the legitimacy of breastfeeding and illness studies. 
The following standards suggested by Kramer (1988) were applied. First of all, 
subjects were divided into groups based on exclusivity of breastfeeding rather 
than any duration of breastfeeding. Breastfeeding has often been shown to be 
more beneficial when examined in terms of exclusivity rather than any amount of 
breastfeeding mixed with formula feeding (Raisler et al., 1999 & Wright et al., 
1998). Second, exclusive breastfeeding was examined at intervals throughout the 
first year of life since the positive effects of breastfeeding may or may not be 
delayed and because the protective effects of breastfeeding have been shown to be 
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dose responsive (Dell & To, 2001). Third, infant feeding data was collected 
during a routine clinic visit without knowledge of the infant’s disease state to 
prevent bias. Feeding data was also collected at the end of the child’s first year of 
life rather than after the elapse of several years in hopes of obtaining a more 
accurate recall from the infants’ parents or caregivers. Fourth, the outcome 
variable, physician diagnosed RSV positive wheezing illnesses, was clearly 
defined and was ascertained prospectively. The infants were examined by a 
physician at two, four, six, nine, and twelve months of age during the first year of 
life. This helped to lessen detection bias. Fifth, the severity, rather than just the 
presence, of the outcome variable was assessed by looking at the occurrence of 
wheezing in addition to an RSV positive illness. Sixth, subjects were classified 
based on maternal history of allergy and/or asthma as this factor can influence the 
results. Finally, extraneous variables were controlled for in the analysis to help 
prevent certain sources of confounding, and the seasonal nature of certain 
respiratory illnesses was accounted for by enrolling equal numbers of infants from 
different seasons in the COAST study. 
Although the standards were met, certain aspects would need to be 
improved if a similar study were to be conducted in the future. For example, other 
potential sources of confounding were not analyzed. One source of confounding 
may be attendance at day care. Infants placed in day care have been shown to 
have more respiratory illnesses (Holberg et al., 1991; Rylander et al., 1993). A 
RSV Positive Wheezing Illnesses 78
more recent study found that exposing infants to viral infections at day care was 
protective against asthma later in life but not against wheezing type illnesses 
(Infante-Rivard, Amre, Gautrin, & Malo, 2001). Additionally, maternal education 
and familial income, two possible confounding variables were not controlled for 
in the analysis. According to the Wisconsin Department of Health and Family 
Services, roughly 95% of mother’s with an education beyond high school access 
prenatal care in the first trimester of pregnancy versus 65% of mothers with less 
than a high school education (2000). Lack of prenatal care could influence the 
health status of the infant in the long run. Next, the initiation of solid feedings was 
not examined. Although infants may have been exclusively breastfed throughout 
the first year of life, the timing and type of solid foods given to the infant may 
have had an impact on the outcome variable as well. Furthermore, even though 
infant feeding history was obtained at one year of age, it is known that 
breastfeeding mothers may overestimate length of exclusive breastfeeding and 
underestimate length of formula feeding.  
The study also failed to have adequate statistical power because many of 
the comparison groups were small in size. For instance, the results of this study 
showed that maternal history of allergy and asthma were significantly associated 
with wheezing illnesses and that breastfeeding did not bestow any protective 
benefits. In the study by Wright et al. (2001b), subjects were grouped by maternal 
asthma alone and not the combination of allergy and asthma. Thus, that may be 
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one of the reasons why the study by Wright et al. (2001b) revealed advantageous 
effects of breastfeeding in infancy and not during childhood whereas this 
particular study did not show any valuable outcomes in infancy. It was not 
possible to examine infants with a maternal history of asthma alone, however, as 
the percentage of mothers with asthma only was quite small. 
Finally, exposure to pets and dust mites was not controlled for in the 
analysis. Having a pet in the home may or may not make a child more susceptible 
to wheezing or asthma based on such factors as a family history of allergy and/or 
asthma. For example, are the pets kept outside or are they kept inside and allowed 
to sleep with the children? Earlier studies have shown a linear relationship 
between pet exposure (caged birds) and wheezing bronchitis (Rylander et al., 
1993) as well as dust mites, cat dander, wheezing and damaged lung tissue (Peat 
& Li, 1999). Other studies, however, have found cat dander to either have no 
association with wheezing (Burr et al., 1993), a stronger association with 
wheezing and asthma primarily in older vs. younger children (Apelberg, Akoi, & 
Jaakkola, 2001), or an inverse relationship with wheezing and asthma (Platts-
Mills, Vaughn, Squillace, Woodfolk, & Sporik, 2001). The latter study postulates, 
however, that the exposure may or may not be beneficial to some children with a 
certain genetic makeup. Additionally, the inverse relationship between wheezing 
and pet exposure in younger children may be due to the fact that families with a 
history of allergy and/or asthma often refrain from keeping pets in the home 
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(Apelberg et al., 2001). Regardless, exposure to pets was not included in the 
analysis and may have confounded the results. 
In conclusion, the debate over the role of breastfeeding in relation to 
respiratory illnesses will most likely continue. Nonetheless, the positive 
association between maternal history of allergy and/or asthma and increased 
incidence of wheezing illnesses adds support to the outcomes of previous studies 
in this area showing increased incidence of wheezing or asthma in childhood with 
a maternal history of asthma (Wright et al., 2001b; Wright et al., 2000; Wright et 
al., 1995). After conducting an extensive literature review, this appears to be the 
only study that reveals that breastfeeding is not protective during infancy when 
maternal history of allergy and/or asthma is taken into consideration. Thus, 
additional research needs to be conducted to expand on this notion that infants, in 
addition to children, with a genetic predisposition for wheezing illnesses are not 
offered supplementary protection from breastfeeding,  
Although this study did not find breastfeeding to be beneficial in reducing 
the prevalence of RSV positive illnesses both with and without the presence of 
wheezing among a group of infants with a strong maternal history of allergy 
and/or asthma, there is no reason to discourage families from this method of 
feeding. The socioeconomic status of the population under study as well as the 
small number of infants who never breastfed, who were never exposed to smoke, 
and who were of non-Caucasian origin could have potentially biased the results.  
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Numerous other studies have revealed a positive relationship between 
breastfeeding and a reduction in the number or severity of respiratory illnesses 
(Baker et al. 1998; Beaudry et a1., 1995; Cunningham, 1979; Cushing et al., 
1998; Dell & To, 2001; Downham et al., 1976; Howie et al., 1990; Oddy et al., 
1999; Raisler et al., 1999; Rylander et al., 1993; Saarinen, & Kajosaari, 1995; 
Wilson et al., 1998; Wright et al., 1998; Wright et al., 1989). The general benefits 
of breastfeeding are also too great to ignore. The infant and mother will increase 
their bonding while the infant receives a source of nutrition that was specially 
designed to meet his or her needs for growth and development. It remains 
important to encourage exclusive breastfeeding for the first six months of life and 
breastfeeding alongside supplemental foods until at least one year of age as 
recommended by the American Academy of Pediatrics (1997) and the American 
Dietetic Association (Dobson & Murtaugh, 2001). These recommendations are 
also evident through the goals of Healthy People 2010 (U. S. Department of 
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PATIENT INFORMATION AND CONSENT FORM 
 
STUDY TITLE:  Cytokine Dysregulation, Viruses, and Childhood Asthma 
PRINCIPAL INVESTIGATOR:  Robert F. Lemanske, Jr., M.D.  
CO-INVESTIGATOR:  James E. Gem, M.D.  
 
INTRODUCTION: 
This informed consent describes the procedures and your role as a participant in this research 
study. Before agreeing to participate in this research study, it is important that you read and 
understand the following explanations of the proposed procedures. Please read this information 
carefully and do not hesitate to ask the study doctor or study coordinator any questions. You must 
sign this informed consent before you and your child may enter the study. 
THE NATURE AND PURPOSE OF THIS STUDY: 
Asthma is a growing medical concern particularly in children, causing recurrent episodes of 
wheezing, breathlessness, chest tightness, and cough particularly at night and/or in the early 
morning. Although asthma may begin soon afterbirth, the natural history of the disease is poorly 
understood. Both genetic (one or both parents having a history of allergies or asthma) and 
environmental (specifically viral respiratory tract Infections) factors have been considered to be 
important in the development of asthma. Identification of genetic markers of asthma may allow 
screening of high-risk children, permitting better targeting of avoidance measures. Many young 
children wheeze during viral respiratory infections, but the relationship of these episodes to the 
development of asthma later in life is not well understood. Studies of young children are needed to 
test the suspicion that genetic or inheritable factors, combined with early lower respiratory 
infections, may predict the future development of asthma. The main purpose of this study is to 
evaluate whether the development of childhood asthma requires the presence of a genetic 
component and an environmental component (development of a clinically significant lower 
respiratory tract infection in the first year of life). If you agree to participate In this study, you will 
be one of approximately 200 families enrolled. This study is being conducted at this center only 
and is funded by the National Institutes of Health (NIH). 
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WHAT DOES STUDY PARTICIPATION INVOLVE? 
This study will be conducted over a three year period (approximately). It will begin at the time you 
sign this consent and will continue until your child is three years old. You may be eligible for this 
study if you are expectant parents, at least one of which has a history of allergies or asthma. 
Eligibility will be determined at a prescreen visit before the birth of your baby. If you are eligible 
and do decide to participate, you will need to visit the study center at least six times during the 
three years of the study. Three of the study visits will take place at your child’s primary care 
provider’s office. Each of these visits will last approximately 1/2 to 1 hour. 
 
Study Procedures 
Parent medical and family history (once) 
Update parent allergy/asthma/family history (nine times) 
Child physical exam (nine times) 
Parent allergy skin testing (one time for each parent) 
Parent blood draw for laboratory tests (onetime for each parent) 
Cord blood sample at birth 
Child blood draws for laboratory tests (three times) 
Child questionnaire (nine times) 
Nasal mucus sampling from child (minimum nine times and with any occurrence of lower 
respiratory infection) 
Nasopharyngeal throat swab samples from child (minimum nine times and with any occurrence of 
lower respiratory infection symptoms) 
 
Explanation of study procedures 
Blood draws To evaluate the possible genetic phenotype (hereditary) and environmental 
components of asthma, blood samples will need to be obtained from both parents and your child. 
The blood samples will be obtained from a vein and will be tested for immunologic factors to help 
us learn more about how heredity influences the development of allergies and asthma. Your 
child’s blood will also be evaluated to see how the type of viral infections he/she may have had 
has affected these factors. Your baby’s blood (approximately 1 tablespoon) will be obtained three 
times during the three years of the study. One blood sample will be obtained from each parent. 
 
DNA Testing As an additional question, we are asking you to consider permitting us to processes 
and to store a portion of the blood sample obtained from you and your child for future DNA 
examination. We anticipate that new knowledge about the asthma and allergy genes may be 
available in the next several years. Therefore, we are asking you now to consider the storage of 
blood samples in anticipation of these future scientific discoveries. The blood samples from you 
and your child could contribute to a better understanding as to how and why asthma and allergies 
may be inherited. 
 
If you agree to the storage of blood for future DNA research, it is essential that we are able to 
update your medical history at the time the DNA would be evaluated in the future. Therefore, 
please let the study coordinator knows if you move or change doctors so that you can provide us 
with this information. If significant changes in your health do occur in the future, we may ask your 
permission to obtain a second blood sample to permit a comparison with the sample to be drawn 
shortly. Dr. Lemanske may also want to use your stored DNA as a shared research effort with 
other researchers investigating the origins of childhood asthma. 
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Since this is a research project and not part of your regular medical care, we do not intend to use 
the results of this study to determine your risk of developing asthma or allergic disease. While we 
hope this research may help someday lead to a test that will identify people with an increased risk 
of asthma or allergic disease, we do not know if that will happen. Even if a test is developed, a 
number of problems may occur that can make it risky to use the test to diagnose patients. The test 
may not be accurate or reliable for everyone, it may not lead to more effective medical treatment, 
or it might actually be harmful (see the Risks section). For these reasons, no results from the 
testing of your blood sample will be shared with you, your doctor, or anyone else. In other words, 
this part of the study will not help you understand your family’s risk of developing asthma or 
allergies. See the “Alternatives” section for other ways your risk may be determined. 
It is important for you to know that if you choose not to have some of your or your child’s blood 
stored for future DNA analysis, you and your child are still eligible to participate fully in this 
research project. 
Let us know whether Dr. Lemanske or others may use you and your child’s DNA for future 
research by putting your initials by as many choices that apply: 
MOTHER: 
____we may not use you or your child’s DNA for any future research or share it with other 
investigators. 
____may use you and your child’s DNA for research only as it relates to asthma or allergic disease 
at our site. 
____we may use you and your child’s DNA for asthma or allergy research being conducted at 
other sites. All identifying information will be removed from the specimen prior to sharing with 
another researcher. 
____we may use you and your child’s DNA for other asthma and allergy research or share it with 
other researchers only after contacting you and getting your permission. 
FATHER: 
____we may not use you or your child’s DNA for any future research or share it with other 
investigators. 
____we may use you and your child’s DNA for research only as it relates to asthma or allergic 
disease at our site. 
____we may use you and your child’s DNA for asthma or allergy research being conducted at 
other sites. All identifying information will be removed from the specimen prior to sharing with 
another researcher. 
____we may use you and your child’s DNA for other asthma and allergy research or share it with 
other researchers only after contacting you and getting your permission. 
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Allergy skin testing: Expectant fathers will be skin tested at the pre-screen visit and mothers 
within the first two months following the birth of your baby. Fourteen drops of dissolved extract 
of common allergens (such as house dust mite, pollen, grass) will be placed on the skin of your 
forearm and your underlying skin will be lightly pricked with a sterile disposable needle. Fifteen 
minutes later, your skin will be inspected for localized redness and swelling. 
Nasal mucus sampling: A bulb or regular syringe/tube will be used to collect the mucus from 
your child’s nose. Up to three milliliters (about half a teaspoon-dependant upon size of child) of 
sterile salt water will be administered to each nostril by squeezing the bulb/regular syringe. The 
bulb/regular syringe will then be released, suctioning the fluid back into the bulb/syringe to help 
wash out the small amount of nasal secretions that are normally present in all noses. 
Throat swabs: To collect the sample, your child’s throat will be swabbed with a cotton- tipped 
applicator using the normal procedure for throat cultures. 
Visits: 
Prescreen Visit: 
This visit will take approximately 1/2 to 1 hour and must occur before the birth of your baby. It is 
preferable that both parents be present at this study visit; however, it is not required. During this 
visit at the study center, the study coordinator will ask you questions about your medical history, 
particularly your history of allergies and asthma, The study coordinator will also perform allergy 
skin testing on expectant fathers to help determine whether you are eligible to participate. Mothers 
will have allergy skin testing and a blood sample obtained after the birth of your child. This visit 
will be scheduled at the study center within two months after the birth of your child at your 
convenience. Fathers will have a blood sample drawn after the birth of the baby as well. The blood 
samples will be tested for immunologic factors to help us learn more about how heredity 
influences the development of allergies and asthma. 
Birth of your baby: 
There is a possibility that you may not be eligible for the study even after you have signed the 
consent form. This may be the case if your infant would have an Apgar score of six or less at five 
minutes of age. An Apgar score is given at birth and again five minutes after birth by a physician 
as an indicator of a newborn’s health status. If your infant is delivered prematurely (before 37 
weeks gestation) or very late in gestation (43 weeks or more) you will not be eligible. Similarly, if 
your baby is born with any significant birth defects or newborn illnesses, you will not be able to 
participate. If your family is eligible after the birth of your baby, a sample of your baby’s cord 
blood will be obtained at the hospital. This blood will only be tested for immunologic factors to 
help us learn more about how heredity influences the development of allergies and asthma. This 
blood is obtained from the placenta or “afterbirth” tissue and does not involve any discomfort to 
your newborn baby. 
Visits 1 and 2: 
These visits will take approximately 1 hour (this includes the exam with your child’s MD, 
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the study portion of the visit will add approximately 15-30 minutes) and will be done when your 
baby is approximately 2 and 4 months old during scheduled well-baby checks at your child’s 
primary health care provider’s office. A brief update of the parental questionnaire completed at the 
prescreen visit will be done. A child’s questionnaire will be completed to evaluate your child’s 
health since birth. Questions about your home environment such as where your child usually 
sleeps will also be asked to help us evaluate the role of environmental factors on the possible 
development of allergies of asthma. Your child will be seen by his/her primary care provider and 
will have a physical examination. To evaluate how viral respiratory infections may impact the 
development of asthma, nasal mucus/throat swab sampling will be obtained to look for viruses in 
the samples. 
Visit 3: 
This visit will be performed when your child is approximately 6 months old. The visit will take 
approximately 1 hour and will be scheduled at the study center. The procedures at this visit 
include a physical examination of your child by a physician, parent and child health 
questionnaires, and nasal mucus/throat swab samples. 
Visit 4: 
This visit will be performed when your child is approximately 9 months old. The visit will take 
approximately 1 hour and will be scheduled at either the study center or your child’s primary 
health care provider’s office. The procedures at this visit include a physical examination of your 
child by a physician, parent and child health questionnaires, and nasal mucus/throat swab samples. 
Visit 5: 
This visit will be completed when your child is approximately one year old and will be scheduled 
at the study center. Procedures at include a physical examination of your child by a physician, 
parent and child health questionnaires, nasal mucus/throat swab samples, and blood samples from 
the child. 
Visit 6: 
This visit will be done when your child is approximately I Y2 years old. Visit procedures 
will be the same as at visit 3. 
 
Visit 7: 
This visit will be done when your child is two years old and will be identical to visit 5. 
Visit 8: 
This visit will be performed when your child is 2V years old and will be the same as 
procedures outlined for visit 3. 
 
Visit 9: 
This visit will be done when your child is three years old and is the same as visit 5. 
To evaluate how viral respiratory infections may impact the development of asthma, collection of 
nasal mucus and throat swab samples will also be required when your child becomes ill with 
certain respiratory infection symptoms. Respiratory infections are characterized by fever, 
wheezing, and/or coughing, and chest/nasal congestion. The collection of these samples will be 
done at the time of presentation to your child’s physicians clinic for a “sick visit”, as a home visit, 
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or at the study center and should ideally be performed within 72 hours of the onset of his/her 
symptoms meeting the predetermined criteria for the study. 
 
WHAT ARE THE BENEFITS OF STUDY PARTICIPATION? 
There is not likely any direct medical benefit to you or your child for participation in this study. It 
may be a benefit to you and your child’s primary physician to have information regarding virus 
identification from nasal mucus and throat samples available after sampling. The societal benefits 
of this study may be invaluable. The information we collect about how hereditary and 
environmental factors impact on the development of asthma could be helpful in addressing the 
issues surrounding primary prevention of childhood asthma in the future. Some people also find 
satisfaction in contributing to scientific knowledge. 
WHAT ARE THE RISKS? 
Drawing blood from a vein may cause discomfort, possible bruising or swelling at the site of 
injection, and on rare occasions, a minor infection may result from this procedure. You and your 
child may have a cream celled EMLA applied to your skin before the needle stick, which can 
decrease the hurt and may cause a rash. Side effects are unlikely with the use of EMLA® cream 
due to the small dose absorbed. 
DNA will be extracted from your blood and analyzed for possible variations in certain genes 
related to asthma, allergic disease, and respiratory infections. Should your child develop asthma, 
and should this research result in the identification of a genetic link to the development of asthma, 
effect of this genetic knowledge will be irrelevant for your child since the condition has already 
been diagnosed. Should your child not develop asthma, but through testing it is learned that your 
child has the genetic makeup that is associated with an increased risk for the development of 
asthma, there is the remote possibility that this knowledge could affect insurability for your child. 
However, a number of facts are important for you to know. First, no study records or testing 
information will be released to insurance carriers unless you so request. Second, your insurance 
carrier will only know that this information has been collected if you disclose it to them. Finally, it 
is illegal in the state of Wisconsin for employers to discriminate against you on the basis of this 
genetic information. Federal law provides limited protection against discrimination by insurance 
companies based on genetic information, but the law does not apply to every situation. 
Your child may experience mild irritation at the opening of the nose where the bulb syringe is 
placed during the nasal mucus collection, however this is very rare. Instilling sterile buffered 
saline should not burn, but may feel uncomfortable for a few minutes secondary to a dripping 
feeling until the solution is auctioned back into the bulb syringe. There could bean extremely rare 
occurrence of an abrasion to the nasal lining if the child were to suddenly jerk his/her head during 
attempts to obtain the mucus sample. This is very unlikely since the tip of the bulb syringe is very 
soft and will not be advanced into the nose to any significant extent. 
Allergy skin testing carries the risk of itching and burning at the site of the test, and the discomfort 
of the needle prick. In extremely rare cases, exposure of allergic people to an allergen can result in 
“anaphylaxis”, a term which describes a serious combination of medical problems including 
severe asthma (chest tightness, coughing, shortness of breath), hives or a rash on your skin, 
swelling of your skin or tongue, itchiness of your skin and fall in blood pressure. In very rare 
instances anaphylactic reactions can result in death. Facilities and medications are available for 
treatment of severe allergic reactions and anaphylaxis if they should occur and a physician will be 
nearby when the skin test is performed. 
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WHAT ALTERNATE THERAPIES TO STUDY PARTICIPATION ARE AVAILABLE? 
You do not have to participate in this research. As alternatives to participating in this study, you 
and your child can choose not to participate or to participate in other investigational studies. You 
and your child would then receive the usual well baby care and check-ups. It is important to 
remember that this study will not help you learn your risk of asthma or allergic diseases. If you 
would be interested in determining your risk of developing asthma or allergic disease once such a 
test becomes available, reliable, and helpful, you should periodically ask you doctor or a genetic 
counselor if the test is available, and ask him or her to discuss its advantages and disadvantages 
with you. (A genetic counselor is professionally trained to help you understand what genetic test 
results mean and don’t mean for you and members of your family). 
WILL THERE BE COMPENSATION FOR INJURY? 
In the event that physical injury occurs as a result of this research, medical care, including 
hospitalization, is available; however the University of Wisconsin, Meriter Hospital, and St. 
Mary’s Hospital do not automatically provide reimbursement for medical care or other 
compensation. If physical injury is suffered in the course of the study or for more information, 
please notify the investigator in charge, Dr. Robert Lemanske at (608) 263-8539. 
WILL THERE BE ANY COSTS TO YOU? 
There will be no cost for any study-related visits, procedures, or blood tests at the study center as 
well as study-related nasal mucus and throat swab samples performed at your child’s physician’s 
clinic when your child is ill with certain respiratory infection symptoms. 
VOLUNTARY PARTICIPATIONIW1THDRAWAL FROM STUDY: 
Participation in this study Is entirely voluntary. You may decide not to participate or to 
discontinue participation at any time without penalty or loss of benefits to which you are otherwise 
entitled. You are encouraged to contact the study doctor or coordinator should you decide not to 
continue your participation in this study. Deciding not to participate will not affect your baby’s 
medical care in any way. Although it is not anticipated, your participation in this study may be 
terminated by the study center if you do not follow study Instructions or for administrative 
reasons. If you allow the storage of blood for DNA testing and once the researchers begin studying 
your DNA, there are two ways you can withdraw from this aspect of the study. One is to ask Dr. 
Lemanske and his colleagues to remove all identifying information associated with your sample. 
The other is to ask them to destroy any of your remaining DNA or tissue. Both of these options 
(especially the second one) could be damaging to the research project, especially if the 
information from your sample turns out to be important. Therefore we are asking you to think very 
carefully about the reasons why you might change your mind, and be as sure as you can that you 
will not withdraw after your sample is taken. If you initially agree to the storage of blood for DNA 
testing, and then later decide to not allow the DNA testing to proceed, you may still participate in 
all other aspects of the study if you wish. 
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WILL THERE RE ANY COMPENSATION? 
Recognizing that this study will require extra time and effort, you will be paid $500.00 for your 
participation. This amount will be prorated according to the following scale based on study visits 
completed: 
Screening visits: 
Father Skin test & blo&1 draw $25.00 
Mother Skin test & blood draw 
(After birth of baby) $25.00 
Visits 1-9: $50.00 each 
Total = $500.00 
In addition, your child will be paid a total of $15.00 for nasal mucus and throat swab samples that 
are obtained from your child at the time of illness. 
We highly encourage that a portion of this money be used for the betterment of your child’s 
development (i.e. investments, savings, or an educational fund). Usable items that will serve 
doubly as reminders (such as stickers, medicine droppers, magnet, etc.) will be given after every 
study visit in appreciation of your commitment to helping us learn more about asthma and allergic 
disease. 
WHO WILL SEE THE STUDY RECORDS? 
Your study physician and coordinator will treat your identity with professional standards of 
confidentiality. Your medical records may be accessed and reviewed by study personnel for the 
purpose of verifying medical history pertinent to determining your eligibility for study 
participation. Some aspects of the medical information gathered from this study (for example, the 
virus identification reports that will be sent to your primary care provider) may become part of 
your child’s permanent medical record. No DNA information collected by the study doctor and 
staff will become part of your permanent medical record. 
Your records regarding this study may be subject to review by appropriate officials of the 
University of Wisconsin should the need arise. No study records or information will be released to 
insurance carriers unless you so request. Your insurance carrier will only know that this 
information has been collected if you disclose it to them. Additionally the medical information and 
records gathered from this study may be submitted to the National Institutes of Health and their 
agents. The results of this study may be published in scientific journals or be presented at medical 
meetings, however you and your child will not be identified by name. 
WHO WILL ANSWER QUESTIONS? 
Please feel free to ask questions at anytime. You may take as long as necessary to decide whether 
you wish to participate in this study. In addition, if you have questions concerning your rights as a 
research subject, you may contact one of the patient representatives at (608) 263-8009. 
The doctor in charge of the study is Dr. Robert F. Lemanske, Jr. He is a pediatrician specializing 
in allergy and immunology and is a Professor at the University of Wisconsin Medical School. If 
you have any questions about this research or believe you have sustained an injury, you can reach 
Dr. Lemanske at his office at the University of Wisconsin at (608) 263-6180 or (608) 263-8539. 
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CONSENT FOR PARTICIPATION AND FUTURE USE OF DNA SAMPLES 
I have read this consent form. I have voluntarily given permission for myself and my child’s 
participation in this research project. I am aware t will receive a copy of this informed consent. 
Signature (mother)__________________________________________Date__________________ 
Signature (father) ___________________________________________Date__________________ 
Signature of person obtaining consent___________________________Date__________________ 
Baby’s full name_________________________________________________________________ 
(To be filled in after birth) 
Signature of person recording baby’s name after birth____________________________________ 
If you have any questions or problems please contact: 




















Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
 
         
1 If you breast fed your baby, at what age (in months)  did you 
completely stop   breast feeding? 
_1 1 month  _7  7 months   _13 Stop when 12-18 mo. of age 
_2 2 months  _8  8 months  _14  Stop when 18-24 mo. of age 
_3 3 months  _9  9 months  _15  Stop when 24-30 mo. of age 
_4 4 months   _10 10 months _16 Still breast feeding 
_5 5 months  _11 11 months _17 Did not breast feed. 
_6 6 months  _12 12 months  
  
3. If you supplemented with formula during the time that you breast 
fed your baby,   at what age (in months) did you start supplementing? 
_1 1 month  _7 7 months   _13  Never used formula,  
_2 2 months  _8 8 months                             started feeding milk            
_3 3 months  _9 9 months                               about one year        
_4 4 months   _10 10 months 
_5 5 months  _11 11 months  
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Appendix C 
Sex of the Child 
COAST 
Childhood  






Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
 
Please answer the questions as frankly and accurately as possible about 
your child.  
 
Choose ONE box per question unless otherwise indicated.   ALL 
INFORMATION OBTAINED IN THE STUDY WILL BE KEPT 
CONFIDENTIAL.  
 
A. Sex of your child    _1 Male    _2 Female 
 






















 _1   Caucasian   
 _2  African-American 
_3  Asian/Pacific Islander        
_4   American Indian/Eskimo 
 _5   Hispanic / Latino      




25.  Father 
 _1   Caucasian   
 _2  African-American     
_3  Asian/Pacific Islander    
_4   American Indian/Eskimo 
 _5   Hispanic / Latino      
_99   Other, specify _____________ 











Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date _ _-_ _-_ _ _ _  
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
 
45b.  Do you still smoke cigarettes?   _1 Yes    _2 No 
   











Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date _ _-_ _-_ _ _ _  
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
 
46.   Since the last visit, has there been a  _1 Yes    _2 No  
 change in your smoking status? 
  
46a.  If yes, please mark the appropriate box.  
_1 Increased  _2 Decreased _3 Quit  
 




















Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
 
 4. Is your child exposed to passive    _1 Yes    _2 No 
 smoke (cigarette) at day care 
   
COAST 
Childhood  






Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
 
4. Is your child exposed to passive    _1 Yes    _2 No 










Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer ________________ 




117.  Does child’s mother smoke? _1 Yes    _2 No _3 N/A 
 
120. Does child’s father smoke?   _1 Yes    _2 No  _3 N/A 
 
123. How many people who live in child’s home smoke? ________ 
 
124. Does anyone else who takes care  
 of child smoke?   _1 Yes    _2 No 
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Appendix F 
Maternal History of Allergy and/or Asthma 
COAST 
Childhood  





Allergy Skin Test 
Results 
Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Test date ___ ___ ___ 
               Month day year 
test completed by : __________ 
Interviewee ID # __________ 
 
2. Alternaria _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
3. Tree Fluid _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____mm 
 
4. Cladosporium _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
5.   Grass Mix _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
6. Aspergillus _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
7. Ragweed _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
8. D. Farinae _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
9. Weed Mix _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
10. D. Pteryn _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
11. Dogs  _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
12 Cockroaches _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
 
13 Cats  _1 Yes _2 No  ____ mm/ ____ mm____ mm/ ____ mm 
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COAST 
Childhood  






Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
  
 
Questionnaire to be completed by parent regarding self. 
 
5. Has your asthma diagnosis been confirmed by an MD?  
_1 Yes    _2 No   _3 N/A 











Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date _ _-_ _-_ _ _ _  
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
 
ABOUT YOUR HEALTH 
 
1.  Have you ever had allergies or asthma?  _1 Yes    _2 No                                
 
2.  Have you ever had an asthmatic attack? _1 Yes    _2 No 
 
Asthma . . .  
3.  About what age did the asthma start?    _1  < 5 years    
       _2  5-10 years 
       _3  11-20 years 
       _4  21-30 years    
       _5  31-40 years 
       _6  >40 years 
            _7   N/A 
 
4. Was asthma confirmed by a doctor? _1 Yes    _2 No   _3  N/A 
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COAST 
Childhood  






Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date _ _-_ _-_ _ _ _  
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
 
ABOUT YOUR HEALTH 
 
 
1.   Since the last visit, have you developed  _1 Yes    _2 No 
 allergies or asthma?     
 
4. Was asthma confirmed by a doctor? _1 Yes    _2 No   _3  N/A 













Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer 
________________ 
Interviewee ID # __________ 
 
 
3.   How many days ago did the illness begin?  __1 1-3 days 
  (If convalescent follow up, ask:)    __2 4-6 days 
 How long did the illness last?   __3 7-10 days 
        __4 11-14 days  
        __5  15-21 days 
        __6 > 21 days 
 
3a.  ONSET DATE:       
    _______/______/______    
 
 
3b. Have you taken your child to a health care  professional for these 
symptoms at any time during this illness?  _1 Yes    _2 No  
 
3c. If yes, please list date(s) and location(s): 
___________________________________________________________ 
 
4.Has your child received any medicine at all since this illness began? (If 
convalescent ask:... since the MD visit)         __1 Yes    __2 No 
 IF YES, WHAT WAS THE MEDICINE?  (Check all that apply) 
1. ___ Tylenol/Motrin 
2. ___ OTC Antihistamine (Triaminic, benedryl, etc.) 
3. ___ Albuterol Elixir 
4. ___ Antibiotic _____________________________ 
5. ___ Anti- fungals (such as Gentian violet or Nystatin) 
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6. ___ OTC Cough syrup (pediacare, Triaminic)  
7. ___ Albuterol Nebulizer treatments/ Albuterol inhaler 
8. ___ Oral Steroids (such as prelone, prednisolone or prednisone)  
9. ___ Inhaled steroids such as fluticasone, budesonide, triamcinolone, or 
beclomethasone)  
10.  ___ Nasal Steroids (such as Flonase) 
11. ___ Long term controller medication (other than steroids), such as 
Cromolyn or Montelukast  
12.  ___ Other Bronchodilators (such as Serevent)  
13. ___ Prescription antihistamine (Zyrtec, Claritin, Allegra)  
14.  ___ Prescription cough medicine (such as Promethazine with codeine)  
15.  ___ Other med – gastrointestinal (Zantac, metochlopramide)  
16.  ___ Other med – skin  
17.  ___ Other med – ENT (eye and ear drops)  
18.  ___ OTC cold medicines  
19.  ___ OTC decongestants  
99. ___ Other _______________________________________________ 
 
7. Overall, is your child..... 
 __1 improving 
  __2 continuing to become more sick 
 __3 staying the same for the past 1-2 days 
 __4 staying the same for the past 3-5 days 
 
Did (Does) your child have any of the following: (check all that apply) 
8.   General symptoms of...... 
 __1 lethargic, “irritable”, “not feeling well” 
__2 not eating as well as prior to illness 
 __3 having diarrhea 
 __4 stuffiness, noisy nose breathing 
 __99 other ___________________________________ 
9. wheezing?     __1 Yes    __2 No   
11. turned blue?     __1 Yes    __2 No 
12. Produced phlegm from the chest or  __1 Yes    __2 No 
 had chest congestion? 











Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer 
________________ 
Interviewer ID # __________ 
           
5.  Please check (_) the presence of the following symptoms (_=1 _=0) 
a.  conjunctivitis  h.  rales  
b.  otitis  i.  rhonchi  
c.  rhinorrhea  **j.  wheezing  
d.  pharyngitis  k.  tachypnea  
e.  cough during exam  l.  retractions/belly 
breathing 
 
f.  cyanosis  m.  diarrhea  
g.  vomiting  z.  Other  
 
8.  Treatment: (mark all that apply)   
a. _ Bronchodilator nebulizer treatment (in office)-    
Improved  __1     Not improved __2      
d. __ Bronchodilators (such as albuterol)   
Oral _____1   Nebulizer_____2     
f.   __ Corticosteriod     
 __1 oral (such as prelone or prednisolone) 
           __2 inhaled (such as fluticasone, budesonide, or beclomethasone) 
 __3 nasal (such as Flonase)   
g. __ Other long-term controllers (non-steroids), including Cromolyn and 
Montelukast  
 
9. Diagnosis (mark all that apply) 
d. ____ Bronchiolitis 
e. ____ Wheezing Illness (non-specific) 
h. ____ Reactive Airway Disease 
i. ____Asthma or Asthma Exacerbation 













Subject ID: _________ 
 
Subject Initials __ __ __ 
 
Visit date ___ ___ ___ 
               Month day year 
Interviewer ________________ 
Interviewee ID # __________ 
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11.  Pulmonary Auscultation (check all that apply)   
 1 No wheezing 
 2 Wheezing on inspiration or expiration 
 3   Adventitious sounds other than wheezing:   
  a Rales    b Rhonchi 
 4 If applicable, describe sounds ______________________________ 
 










Description of Abnormalities 
 
12. Hair and Skin 
12a. Atopic Dermatitis/     
    Eczema __ yes  __ no 
12b. Uticaria/Angioedema 
       __ yes  __ no 
12c. Rash (nonspecified) 
     __ yes  __ no 
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     2 
 
     3 
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